Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients by Cattin, Sarah et al.
padj Fold_Change Gene_ID Associated_Gene_Name Gene_biotype
3.98E-12 24.2892626 ENSG00000136634 IL10 protein_coding
3.30E-09 21.17599146 ENSG00000087116 ADAMTS2 protein_coding
1.14E-06 13.03285315 ENSG00000144476 ACKR3 protein_coding
1.38E-05 11.35501923 ENSG00000115414 FN1 protein_coding
4.60E-06 9.989150636 ENSG00000164105 SAP30 protein_coding
8.73E-05 9.87143423 ENSG00000115009 CCL20 protein_coding
0.00012572 9.154333157 ENSG00000168874 ATOH8 protein_coding
0.00012607 8.755866967 ENSG00000102837 OLFM4 protein_coding
2.29E-05 8.243618216 ENSG00000124145 SDC4 protein_coding
0.00074818 8.217528503 ENSG00000235033 RP11-61I13.3 antisense
0.00077365 8.096085003 ENSG00000152463 OLAH protein_coding
0.00048391 7.834733438 ENSG00000167680 SEMA6B protein_coding
0.00040057 7.829645769 ENSG00000212579 SNORA40 snoRNA
0.00053941 7.145956773 ENSG00000179593 ALOX15B protein_coding
0.00085419 6.971153251 ENSG00000109906 ZBTB16 protein_coding
0.00181565 6.825889009 ENSG00000196935 SRGAP1 protein_coding
0.00025745 6.802834447 ENSG00000242048 RP13-452N2.1 processed_transcript
0.00252535 6.455704426 ENSG00000173391 OLR1 protein_coding
0.00267729 6.447032987 ENSG00000255801 RP11-561P12.5 lincRNA
0.00162397 6.421289756 ENSG00000008056 SYN1 protein_coding
0.00205057 6.313430583 ENSG00000259883 CTD-2382E5.4 antisense
0.00659246 6.116519222 ENSG00000012223 LTF protein_coding
1.32E-05 6.102292269 ENSG00000119138 KLF9 protein_coding
6.67E-05 5.915522704 ENSG00000186354 C9orf47 protein_coding
0.00048391 5.861249797 ENSG00000229989 MIR181A1HG lincRNA
0.00455131 5.777068481 ENSG00000078053 AMPH protein_coding
0.00880161 5.741602082 ENSG00000259345 RP11-624L4.1 antisense
0.00889035 5.686571507 ENSG00000133063 CHIT1 protein_coding
0.01086747 5.62580281 ENSG00000214894 LINC00243 processed_transcript
0.01041047 5.53756841 ENSG00000166033 HTRA1 protein_coding
0.00159673 5.353110969 ENSG00000196781 TLE1 protein_coding
0.00522014 5.266931653 ENSG00000248318 RP11-713M15.1 antisense
0.00880161 5.205744787 ENSG00000140545 MFGE8 protein_coding
0.0090046 5.2046209 ENSG00000106366 SERPINE1 protein_coding
1.96E-05 5.118389118 ENSG00000180509 KCNE1 protein_coding
0.01461478 5.115449256 ENSG00000214650 RP11-83B20.1 lincRNA
0.01927098 5.087506014 ENSG00000197561 ELANE protein_coding
0.02271196 4.994338242 ENSG00000137801 THBS1 protein_coding
0.0247604 4.969247879 ENSG00000138135 CH25H protein_coding
0.024388 4.96798562 ENSG00000118113 MMP8 protein_coding
0.01874308 4.953654271 ENSG00000254864 CTD-2516F10.4 antisense
0.02675057 4.893825376 ENSG00000258376 RP4-647C14.2 antisense
0.00642063 4.871486389 ENSG00000254177 RP11-1149M10.1 lincRNA
3.98E-06 4.869781158 ENSG00000169155 ZBTB43 protein_coding
0.00813461 4.786223188 ENSG00000106070 GRB10 protein_coding
0.0114124 4.736253183 ENSG00000115604 IL18R1 protein_coding
0.00187805 4.733870525 ENSG00000168209 DDIT4 protein_coding
0.03454826 4.672889657 ENSG00000223946 RP11-533O20.2 lincRNA
0.03458201 4.626135006 ENSG00000269956 MKNK1-AS1 antisense
0.00195805 4.536883264 ENSG00000164104 HMGB2 protein_coding
0.00876617 4.512292937 ENSG00000241732 RP11-38P22.2 lincRNA
0.01027444 4.494793596 ENSG00000248905 FMN1 protein_coding
0.01548299 4.483663631 ENSG00000243243 AC073130.3 antisense
0.04148749 4.482329466 ENSG00000189221 MAOA protein_coding
0.00896928 4.399337742 ENSG00000117479 SLC19A2 protein_coding
0.03454826 4.397991584 ENSG00000106089 STX1A protein_coding
0.01157425 4.388442668 ENSG00000151929 BAG3 protein_coding
0.04837986 4.37189775 ENSG00000124882 EREG protein_coding
0.01085012 4.370218982 ENSG00000239300 RP11-400L8.2 antisense
0.03265133 4.350202237 ENSG00000231201 AF127577.11 antisense
0.00889035 4.285461409 ENSG00000175592 FOSL1 protein_coding
0.00493588 4.268924345 ENSG00000151014 CCRN4L protein_coding
0.03381081 4.212848248 ENSG00000129277 CCL4 protein_coding
0.03483176 4.184307067 ENSG00000162772 ATF3 protein_coding
0.01548299 4.161948089 ENSG00000120254 MTHFD1L protein_coding
0.01789235 4.155822562 ENSG00000243637 AC019221.4 processed_transcript
0.00042373 4.131441827 ENSG00000204103 MAFB protein_coding
0.00252535 4.105766771 ENSG00000147872 PLIN2 protein_coding
0.00030699 4.097125703 ENSG00000183696 UPP1 protein_coding
0.03454826 4.077086816 ENSG00000182118 FAM89A protein_coding
0.04837986 4.012665363 ENSG00000169902 TPST1 protein_coding
0.04112561 3.994456512 ENSG00000169860 P2RY1 protein_coding
0.01444534 3.942468424 ENSG00000169439 SDC2 protein_coding
0.01157425 3.909954559 ENSG00000270103 RNU11 lincRNA
0.04931943 3.901435418 ENSG00000233912 AC026202.3 antisense
0.00187805 3.899838444 ENSG00000122644 ARL4A protein_coding
0.00494067 3.894721026 ENSG00000113070 HBEGF protein_coding
0.03381081 3.893838432 ENSG00000267009 RP11-120M18.2 processed_transcript
0.00469189 3.880780845 ENSG00000140044 JDP2 protein_coding
0.04767695 3.859763571 ENSG00000171729 TMEM51 protein_coding
0.02436767 3.844402767 ENSG00000148773 MKI67 protein_coding
5.07E-05 3.736143097 ENSG00000169826 CSGALNACT2 protein_coding
0.02655509 3.70313951 ENSG00000096060 FKBP5 protein_coding
0.04837986 3.683366543 ENSG00000262194 CTD-3195I5.5 lincRNA
0.00155726 3.674232785 ENSG00000198363 ASPH protein_coding
0.01317721 3.650793048 ENSG00000060982 BCAT1 protein_coding
0.04497013 3.614028509 ENSG00000155659 VSIG4 protein_coding
0.03869619 3.600128819 ENSG00000102760 RGCC protein_coding
0.02474235 3.594234653 ENSG00000153208 MERTK protein_coding
0.03943594 3.593373629 ENSG00000178726 THBD protein_coding
0.02675057 3.574913464 ENSG00000100036 SLC35E4 protein_coding
0.00493588 3.574602074 ENSG00000136478 TEX2 protein_coding
0.03381081 3.521246129 ENSG00000158874 APOA2 protein_coding
0.0051205 3.462974268 ENSG00000229619 MBNL1-AS1 antisense
0.00061376 3.425993962 ENSG00000166484 MAPK7 protein_coding
0.02466137 3.405776153 ENSG00000136068 FLNB protein_coding
0.00163605 3.380948618 ENSG00000135503 ACVR1B protein_coding
0.01778601 3.329809726 ENSG00000224186 C5orf66 protein_coding
0.01927098 3.299325108 ENSG00000119686 FLVCR2 protein_coding
0.00055705 3.278380545 ENSG00000162711 NLRP3 protein_coding
0.00095841 3.18771035 ENSG00000176014 TUBB6 protein_coding
0.04976228 3.185631457 ENSG00000236256 DIAPH2-AS1 antisense
0.00304222 3.183744088 ENSG00000168036 CTNNB1 protein_coding
0.00125347 3.13491741 ENSG00000125384 PTGER2 protein_coding
0.01717344 3.134234974 ENSG00000107372 ZFAND5 protein_coding
0.01689488 3.128188889 ENSG00000125730 C3 protein_coding
0.00891869 3.115623294 ENSG00000108828 VAT1 protein_coding
0.04724825 3.036953962 ENSG00000175556 LONRF3 protein_coding
0.04048126 3.026984331 ENSG00000221869 CEBPD protein_coding
0.03133473 3.023145742 ENSG00000101384 JAG1 protein_coding
0.03009028 3.019153639 ENSG00000145685 LHFPL2 protein_coding
0.03330226 2.992519057 ENSG00000135678 CPM protein_coding
0.01874308 2.97120715 ENSG00000145990 GFOD1 protein_coding
0.02529827 2.955417963 ENSG00000186767 SPIN4 protein_coding
0.0038848 2.935730214 ENSG00000173744 AGFG1 protein_coding
0.00267729 2.921870004 ENSG00000108219 TSPAN14 protein_coding
0.00716675 2.899244649 ENSG00000124762 CDKN1A protein_coding
0.01085012 2.880514192 ENSG00000173890 GPR160 protein_coding
0.03156889 2.707529395 ENSG00000166387 PPFIBP2 protein_coding
0.03454826 2.698302466 ENSG00000154370 TRIM11 protein_coding
0.039313 2.627793298 ENSG00000139354 GAS2L3 protein_coding
0.03068496 2.609851322 ENSG00000198805 PNP protein_coding
0.01247307 2.54621853 ENSG00000124766 SOX4 protein_coding
0.04611636 2.53820761 ENSG00000135679 MDM2 protein_coding
0.01471939 2.513451723 ENSG00000106789 CORO2A protein_coding
0.03320324 2.502951756 ENSG00000121578 B4GALT4 protein_coding
0.03869619 2.477575104 ENSG00000116260 QSOX1 protein_coding
0.00055705 2.452830156 ENSG00000026025 VIM protein_coding
0.03200258 2.442571768 ENSG00000132326 PER2 protein_coding
0.00544644 2.429764368 ENSG00000118263 KLF7 protein_coding
0.00242749 2.423019534 ENSG00000151694 ADAM17 protein_coding
0.00196152 2.408313006 ENSG00000106546 AHR protein_coding
0.00267729 2.403454077 ENSG00000198734 F5 protein_coding
0.0013149 2.402275695 ENSG00000113648 H2AFY protein_coding
0.01874308 2.384726206 ENSG00000125149 C16orf70 protein_coding
0.00848781 2.288754485 ENSG00000121316 PLBD1 protein_coding
0.01963942 2.251515836 ENSG00000115738 ID2 protein_coding
0.02983222 2.248683015 ENSG00000123643 SLC36A1 protein_coding
0.03480784 2.16614322 ENSG00000070540 WIPI1 protein_coding
0.04015891 2.146822916 ENSG00000088854 C20orf194 protein_coding
0.04651275 2.125503171 ENSG00000120685 PROSER1 protein_coding
0.00501295 1.95987534 ENSG00000116698 SMG7 protein_coding
0.03458201 1.788384024 ENSG00000134333 LDHA protein_coding
0.04767695 -2.120030907 ENSG00000121104 FAM117A protein_coding
0.04767695 -2.185035567 ENSG00000049449 RCN1 protein_coding
0.01613692 -2.322177491 ENSG00000143390 RFX5 protein_coding
0.0497181 -2.377522434 ENSG00000005175 RPAP3 protein_coding
0.0155245 -2.436411314 ENSG00000113456 RAD1 protein_coding
0.02853844 -2.440482333 ENSG00000125249 RAP2A protein_coding
0.01001477 -2.449888035 ENSG00000128335 APOL2 protein_coding
0.03454826 -2.460779201 ENSG00000111653 ING4 protein_coding
0.01765229 -2.493837906 ENSG00000151835 SACS protein_coding
0.0497181 -2.517221372 ENSG00000145349 CAMK2D protein_coding
0.02231733 -2.52284398 ENSG00000149311 ATM protein_coding
0.04544712 -2.525329125 ENSG00000117899 MESDC2 protein_coding
0.02211314 -2.614082035 ENSG00000121858 TNFSF10 protein_coding
0.00891606 -2.717935388 ENSG00000142546 NOSIP protein_coding
0.01717344 -2.786649286 ENSG00000127954 STEAP4 protein_coding
0.00233745 -2.824595191 ENSG00000242574 HLA-DMB protein_coding
0.04301758 -2.831179499 ENSG00000154451 GBP5 protein_coding
0.03330226 -2.864888459 ENSG00000128284 APOL3 protein_coding
0.01776966 -2.890146706 ENSG00000177971 IMP3 protein_coding
0.04014456 -2.920526326 ENSG00000171307 ZDHHC16 protein_coding
0.03089855 -2.950731423 ENSG00000131844 MCCC2 protein_coding
0.03637866 -2.952072446 ENSG00000073849 ST6GAL1 protein_coding
0.01874308 -2.966424799 ENSG00000103319 EEF2K protein_coding
0.00252535 -3.021195586 ENSG00000117228 GBP1 protein_coding
0.03465328 -3.090155881 ENSG00000140280 LYSMD2 protein_coding
0.01727117 -3.159884594 ENSG00000160818 GPATCH4 protein_coding
0.02638625 -3.175896676 ENSG00000231074 HCG18 antisense
0.04497013 -3.180850672 ENSG00000165661 QSOX2 protein_coding
0.00065401 -3.207823047 ENSG00000196405 EVL protein_coding
0.02983222 -3.283107178 ENSG00000179583 CIITA protein_coding
0.02504018 -3.290379224 ENSG00000162654 GBP4 protein_coding
0.04497013 -3.306390415 ENSG00000121310 ECHDC2 protein_coding
0.04506472 -3.308331465 ENSG00000107679 PLEKHA1 protein_coding
0.03200258 -3.463110994 ENSG00000236859 NIFK-AS1 antisense
0.04112561 -3.50752015 ENSG00000026751 SLAMF7 protein_coding
0.03662773 -3.518516352 ENSG00000096654 ZNF184 protein_coding
0.0418283 -3.525869541 ENSG00000197302 ZNF720 protein_coding
0.0497181 -3.548994279 ENSG00000213402 PTPRCAP protein_coding
0.02560651 -3.553480056 ENSG00000166881 TMEM194A protein_coding
0.00880161 -3.644143187 ENSG00000136169 SETDB2 protein_coding
0.02150239 -3.671560552 ENSG00000138755 CXCL9 protein_coding
0.04659673 -3.721589324 ENSG00000150756 FAM173B protein_coding
0.03943594 -3.804255187 ENSG00000198919 DZIP3 protein_coding
0.02340347 -3.849405006 ENSG00000105552 BCAT2 protein_coding
0.0335215 -3.854855242 ENSG00000050438 SLC4A8 protein_coding
0.04506472 -3.855263269 ENSG00000116824 CD2 protein_coding
0.02049077 -3.862663083 ENSG00000198121 LPAR1 protein_coding
0.03064268 -3.891116363 ENSG00000109762 SNX25 protein_coding
0.03454826 -3.92554956 ENSG00000021300 PLEKHB1 protein_coding
0.03462013 -3.926154036 ENSG00000069702 TGFBR3 protein_coding
0.04177857 -3.939870889 ENSG00000126456 IRF3 protein_coding
0.04115495 -4.009777334 ENSG00000156738 MS4A1 protein_coding
0.0120492 -4.100313775 ENSG00000155189 AGPAT5 protein_coding
0.0428173 -4.160152697 ENSG00000198780 FAM169A protein_coding
0.04201879 -4.16273921 ENSG00000073350 LLGL2 protein_coding
0.03381081 -4.164750598 ENSG00000170989 S1PR1 protein_coding
0.00085419 -4.177945298 ENSG00000145246 ATP10D protein_coding
0.0497181 -4.207250286 ENSG00000110448 CD5 protein_coding
0.00049474 -4.242162961 ENSG00000010818 HIVEP2 protein_coding
0.01932212 -4.247593326 ENSG00000180644 PRF1 protein_coding
0.03454826 -4.256404867 ENSG00000178573 MAF protein_coding
0.00029806 -4.27996608 ENSG00000163644 PPM1K protein_coding
0.01927098 -4.310584433 ENSG00000206053 HN1L protein_coding
0.02150239 -4.34372265 ENSG00000122224 LY9 protein_coding
0.04659673 -4.368210227 ENSG00000239951 IGKV3-20 IG_V_gene
0.04837986 -4.377663874 ENSG00000167286 CD3D protein_coding
0.03943594 -4.4362636 ENSG00000143167 GPA33 protein_coding
0.03766184 -4.439474849 ENSG00000171791 BCL2 protein_coding
0.00827817 -4.471392801 ENSG00000111796 KLRB1 protein_coding
0.03943594 -4.507547245 ENSG00000183625 CCR3 protein_coding
0.03943594 -4.518459118 ENSG00000132465 IGJ protein_coding
0.03943594 -4.534375266 ENSG00000124171 PARD6B protein_coding
0.01206463 -4.538873405 ENSG00000161405 IKZF3 protein_coding
0.03924531 -4.548542061 ENSG00000081985 IL12RB2 protein_coding
0.00627131 -4.550471773 ENSG00000107742 SPOCK2 protein_coding
0.00472709 -4.592311129 ENSG00000211899 IGHM IG_C_gene
0.03454826 -4.655624914 ENSG00000162892 IL24 protein_coding
0.00995579 -4.66141812 ENSG00000168803 ADAL protein_coding
0.02773812 -4.671172162 ENSG00000165272 AQP3 protein_coding
0.00074818 -4.725521542 ENSG00000134954 ETS1 protein_coding
0.03089855 -4.785227788 ENSG00000154269 ENPP3 protein_coding
0.02540072 -4.814889403 ENSG00000162739 SLAMF6 protein_coding
0.00055705 -4.857463221 ENSG00000118922 KLF12 protein_coding
0.02655509 -4.909797671 ENSG00000169245 CXCL10 protein_coding
0.01408595 -4.913005274 ENSG00000211689 TRGC1 TR_C_gene
0.01960446 -4.919122268 ENSG00000245164 LINC00861 lincRNA
0.0168038 -4.943492102 ENSG00000168685 IL7R protein_coding
0.00205057 -5.041289955 ENSG00000131848 ZSCAN5A protein_coding
0.00627131 -5.041299587 ENSG00000078589 P2RY10 protein_coding
0.02103278 -5.045473256 ENSG00000131016 AKAP12 protein_coding
0.01548299 -5.056205626 ENSG00000115085 ZAP70 protein_coding
0.01927098 -5.064699294 ENSG00000179841 AKAP5 protein_coding
0.01717344 -5.115706291 ENSG00000178538 CA8 protein_coding
0.00876617 -5.19138766 ENSG00000264198 RP11-94L15.2 lincRNA
0.01408595 -5.206150534 ENSG00000126353 CCR7 protein_coding
0.01076498 -5.382153417 ENSG00000115687 PASK protein_coding
0.00889035 -5.481407778 ENSG00000178202 KDELC2 protein_coding
0.01085012 -5.509137287 ENSG00000162813 BPNT1 protein_coding
0.00455131 -5.642061159 ENSG00000117281 CD160 protein_coding
0.01085012 -5.659134575 ENSG00000197635 DPP4 protein_coding
0.0085244 -5.747892165 ENSG00000124203 ZNF831 protein_coding
0.00933487 -5.756339298 ENSG00000246363 RP11-13A1.1 lincRNA
0.00538077 -5.812681897 ENSG00000163519 TRAT1 protein_coding
0.00444126 -5.894534467 ENSG00000153563 CD8A protein_coding
1.32E-05 -5.898685223 ENSG00000101017 CD40 protein_coding
0.00493588 -5.901489291 ENSG00000185920 PTCH1 protein_coding
0.00289999 -5.920188733 ENSG00000168329 CX3CR1 protein_coding
0.00272429 -5.956323124 ENSG00000160654 CD3G protein_coding
0.00445231 -6.227444064 ENSG00000138795 LEF1 protein_coding
0.00493588 -6.230150564 ENSG00000150687 PRSS23 protein_coding
3.53E-05 -6.27115692 ENSG00000204252 HLA-DOA protein_coding
0.00223855 -6.273989009 ENSG00000069667 RORA protein_coding
0.00205057 -6.471765434 ENSG00000095585 BLNK protein_coding
0.00252535 -6.519937783 ENSG00000181036 FCRL6 protein_coding
0.00155726 -6.611217095 ENSG00000184613 NELL2 protein_coding
0.00267729 -6.833338008 ENSG00000007402 CACNA2D2 protein_coding
0.00163605 -6.881188586 ENSG00000127152 BCL11B protein_coding
0.00163605 -6.972218768 ENSG00000139187 KLRG1 protein_coding
0.00052317 -7.0133729 ENSG00000100385 IL2RB protein_coding
0.00187805 -7.296977104 ENSG00000163508 EOMES protein_coding
0.00025745 -7.590454823 ENSG00000211772 TRBC2 TR_C_gene
0.0007036 -7.715585437 ENSG00000182866 LCK protein_coding
0.00014433 -8.061358514 ENSG00000100450 GZMH protein_coding
0.00012572 -8.461905317 ENSG00000179639 FCER1A protein_coding
0.00020909 -8.90466976 ENSG00000229164 TRAC TR_C_gene
1.32E-05 -9.730497832 ENSG00000145649 GZMA protein_coding
2.38E-08 -12.16053265 ENSG00000109452 INPP4B protein_coding
9.23E-06 -12.30813746 ENSG00000151623 NR3C2 protein_coding
Description
interleukin 10 [Source:HGNC Symbol;Acc:5962]
ADAM metallopeptidase with thrombospondin type 1 motif, 2 [Source:HGNC Symbol;Acc:218]
atypical chemokine receptor 3 [Source:HGNC Symbol;Acc:23692]
fibronectin 1 [Source:HGNC Symbol;Acc:3778]
Sin3A-associated protein, 30kDa [Source:HGNC Symbol;Acc:10532]
chemokine (C-C motif) ligand 20 [Source:HGNC Symbol;Acc:10619]
atonal homolog 8 (Drosophila) [Source:HGNC Symbol;Acc:24126]
olfactomedin 4 [Source:HGNC Symbol;Acc:17190]
syndecan 4 [Source:HGNC Symbol;Acc:10661]
oleoyl-ACP hydrolase [Source:HGNC Symbol;Acc:25625]
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B [Source:HGNC Symbol;Acc:10739]
Small nucleolar RNA SNORA40 [Source:RFAM;Acc:RF00561]
arachidonate 15-lipoxygenase, type B [Source:HGNC Symbol;Acc:434]
zinc finger and BTB domain containing 16 [Source:HGNC Symbol;Acc:12930]
SLIT-ROBO Rho GTPase activating protein 1 [Source:HGNC Symbol;Acc:17382]
oxidized low density lipoprotein (lectin-like) receptor 1 [Source:HGNC Symbol;Acc:8133]
synapsin I [Source:HGNC Symbol;Acc:11494]
lactotransferrin [Source:HGNC Symbol;Acc:6720]
Kruppel-like factor 9 [Source:HGNC Symbol;Acc:1123]
chromosome 9 open reading frame 47 [Source:HGNC Symbol;Acc:23669]
MIR181A1 host gene (non-protein coding) [Source:HGNC Symbol;Acc:48659]
amphiphysin [Source:HGNC Symbol;Acc:471]
chitinase 1 (chitotriosidase) [Source:HGNC Symbol;Acc:1936]
long intergenic non-protein coding RNA 243 [Source:HGNC Symbol;Acc:30956]
HtrA serine peptidase 1 [Source:HGNC Symbol;Acc:9476]
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) [Source:HGNC Symbol;Acc:11837]
milk fat globule-EGF factor 8 protein [Source:HGNC Symbol;Acc:7036]
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 [Source:HGNC Symbol;Acc:8583]
potassium voltage-gated channel, Isk-related family, member 1 [Source:HGNC Symbol;Acc:6240]
elastase, neutrophil expressed [Source:HGNC Symbol;Acc:3309]
thrombospondin 1 [Source:HGNC Symbol;Acc:11785]
cholesterol 25-hydroxylase [Source:HGNC Symbol;Acc:1907]
matrix metallopeptidase 8 (neutrophil collagenase) [Source:HGNC Symbol;Acc:7175]
zinc finger and BTB domain containing 43 [Source:HGNC Symbol;Acc:17908]
growth factor receptor-bound protein 10 [Source:HGNC Symbol;Acc:4564]
interleukin 18 receptor 1 [Source:HGNC Symbol;Acc:5988]
DNA-damage-inducible transcript 4 [Source:HGNC Symbol;Acc:24944]
MKNK1 antisense RNA 1 [Source:HGNC Symbol;Acc:44129]
high mobility group box 2 [Source:HGNC Symbol;Acc:5000]
formin 1 [Source:HGNC Symbol;Acc:3768]
monoamine oxidase A [Source:HGNC Symbol;Acc:6833]
solute carrier family 19 (thiamine transporter), member 2 [Source:HGNC Symbol;Acc:10938]
syntaxin 1A (brain) [Source:HGNC Symbol;Acc:11433]
BCL2-associated athanogene 3 [Source:HGNC Symbol;Acc:939]
epiregulin [Source:HGNC Symbol;Acc:3443]
FOS-like antigen 1 [Source:HGNC Symbol;Acc:13718]
CCR4 carbon catabolite repression 4-like (S. cerevisiae) [Source:HGNC Symbol;Acc:14254]
chemokine (C-C motif) ligand 4 [Source:HGNC Symbol;Acc:10630]
activating transcription factor 3 [Source:HGNC Symbol;Acc:785]
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like [Source:HGNC Symbol;Acc:21055]
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B [Source:HGNC Symbol;Acc:6408]
perilipin 2 [Source:HGNC Symbol;Acc:248]
uridine phosphorylase 1 [Source:HGNC Symbol;Acc:12576]
family with sequence similarity 89, member A [Source:HGNC Symbol;Acc:25057]
tyrosylprotein sulfotransferase 1 [Source:HGNC Symbol;Acc:12020]
purinergic receptor P2Y, G-protein coupled, 1 [Source:HGNC Symbol;Acc:8539]
syndecan 2 [Source:HGNC Symbol;Acc:10659]
RNA, U11 small nuclear [Source:HGNC Symbol;Acc:10108]
ADP-ribosylation factor-like 4A [Source:HGNC Symbol;Acc:695]
heparin-binding EGF-like growth factor [Source:HGNC Symbol;Acc:3059]
Jun dimerization protein 2 [Source:HGNC Symbol;Acc:17546]
transmembrane protein 51 [Source:HGNC Symbol;Acc:25488]
marker of proliferation Ki-67 [Source:HGNC Symbol;Acc:7107]
chondroitin sulfate N-acetylgalactosaminyltransferase 2 [Source:HGNC Symbol;Acc:24292]
FK506 binding protein 5 [Source:HGNC Symbol;Acc:3721]
aspartate beta-hydroxylase [Source:HGNC Symbol;Acc:757]
branched chain amino-acid transaminase 1, cytosolic [Source:HGNC Symbol;Acc:976]
V-set and immunoglobulin domain containing 4 [Source:HGNC Symbol;Acc:17032]
regulator of cell cycle [Source:HGNC Symbol;Acc:20369]
c-mer proto-oncogene tyrosine kinase [Source:HGNC Symbol;Acc:7027]
thrombomodulin [Source:HGNC Symbol;Acc:11784]
solute carrier family 35, member E4 [Source:HGNC Symbol;Acc:17058]
testis expressed 2 [Source:HGNC Symbol;Acc:30884]
apolipoprotein A-II [Source:HGNC Symbol;Acc:601]
MBNL1 antisense RNA 1 [Source:HGNC Symbol;Acc:44584]
mitogen-activated protein kinase 7 [Source:HGNC Symbol;Acc:6880]
filamin B, beta [Source:HGNC Symbol;Acc:3755]
activin A receptor, type IB [Source:HGNC Symbol;Acc:172]
chromosome 5 open reading frame 66 [Source:HGNC Symbol;Acc:48332]
feline leukemia virus subgroup C cellular receptor family, member 2 [Source:HGNC Symbol;Acc:20105]
NLR family, pyrin domain containing 3 [Source:HGNC Symbol;Acc:16400]
tubulin, beta 6 class V [Source:HGNC Symbol;Acc:20776]
DIAPH2 antisense RNA 1 [Source:HGNC Symbol;Acc:16972]
catenin (cadherin-associated protein), beta 1, 88kDa [Source:HGNC Symbol;Acc:2514]
prostaglandin E receptor 2 (subtype EP2), 53kDa [Source:HGNC Symbol;Acc:9594]
zinc finger, AN1-type domain 5 [Source:HGNC Symbol;Acc:13008]
complement component 3 [Source:HGNC Symbol;Acc:1318]
vesicle amine transport 1 [Source:HGNC Symbol;Acc:16919]
LON peptidase N-terminal domain and ring finger 3 [Source:HGNC Symbol;Acc:21152]
CCAAT/enhancer binding protein (C/EBP), delta [Source:HGNC Symbol;Acc:1835]
jagged 1 [Source:HGNC Symbol;Acc:6188]
lipoma HMGIC fusion partner-like 2 [Source:HGNC Symbol;Acc:6588]
carboxypeptidase M [Source:HGNC Symbol;Acc:2311]
glucose-fructose oxidoreductase domain containing 1 [Source:HGNC Symbol;Acc:21096]
spindlin family, member 4 [Source:HGNC Symbol;Acc:27040]
ArfGAP with FG repeats 1 [Source:HGNC Symbol;Acc:5175]
tetraspanin 14 [Source:HGNC Symbol;Acc:23303]
cyclin-dependent kinase inhibitor 1A (p21, Cip1) [Source:HGNC Symbol;Acc:1784]
G protein-coupled receptor 160 [Source:HGNC Symbol;Acc:23693]
PTPRF interacting protein, binding protein 2 (liprin beta 2) [Source:HGNC Symbol;Acc:9250]
tripartite motif containing 11 [Source:HGNC Symbol;Acc:16281]
growth arrest-specific 2 like 3 [Source:HGNC Symbol;Acc:27475]
purine nucleoside phosphorylase [Source:HGNC Symbol;Acc:7892]
SRY (sex determining region Y)-box 4 [Source:HGNC Symbol;Acc:11200]
MDM2 oncogene, E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:6973]
coronin, actin binding protein, 2A [Source:HGNC Symbol;Acc:2255]
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4 [Source:HGNC Symbol;Acc:927]
quiescin Q6 sulfhydryl oxidase 1 [Source:HGNC Symbol;Acc:9756]
vimentin [Source:HGNC Symbol;Acc:12692]
period circadian clock 2 [Source:HGNC Symbol;Acc:8846]
Kruppel-like factor 7 (ubiquitous) [Source:HGNC Symbol;Acc:6350]
ADAM metallopeptidase domain 17 [Source:HGNC Symbol;Acc:195]
aryl hydrocarbon receptor [Source:HGNC Symbol;Acc:348]
coagulation factor V (proaccelerin, labile factor) [Source:HGNC Symbol;Acc:3542]
H2A histone family, member Y [Source:HGNC Symbol;Acc:4740]
chromosome 16 open reading frame 70 [Source:HGNC Symbol;Acc:29564]
phospholipase B domain containing 1 [Source:HGNC Symbol;Acc:26215]
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein [Source:HGNC Symbol;Acc:5361]
solute carrier family 36 (proton/amino acid symporter), member 1 [Source:HGNC Symbol;Acc:18761]
WD repeat domain, phosphoinositide interacting 1 [Source:HGNC Symbol;Acc:25471]
chromosome 20 open reading frame 194 [Source:HGNC Symbol;Acc:17721]
proline and serine rich 1 [Source:HGNC Symbol;Acc:20291]
SMG7 nonsense mediated mRNA decay factor [Source:HGNC Symbol;Acc:16792]
lactate dehydrogenase A [Source:HGNC Symbol;Acc:6535]
family with sequence similarity 117, member A [Source:HGNC Symbol;Acc:24179]
reticulocalbin 1, EF-hand calcium binding domain [Source:HGNC Symbol;Acc:9934]
regulatory factor X, 5 (influences HLA class II expression) [Source:HGNC Symbol;Acc:9986]
RNA polymerase II associated protein 3 [Source:HGNC Symbol;Acc:26151]
RAD1 homolog (S. pombe) [Source:HGNC Symbol;Acc:9806]
RAP2A, member of RAS oncogene family [Source:HGNC Symbol;Acc:9861]
apolipoprotein L, 2 [Source:HGNC Symbol;Acc:619]
inhibitor of growth family, member 4 [Source:HGNC Symbol;Acc:19423]
spastic ataxia of Charlevoix-Saguenay (sacsin) [Source:HGNC Symbol;Acc:10519]
calcium/calmodulin-dependent protein kinase II delta [Source:HGNC Symbol;Acc:1462]
ataxia telangiectasia mutated [Source:HGNC Symbol;Acc:795]
mesoderm development candidate 2 [Source:HGNC Symbol;Acc:13520]
tumor necrosis factor (ligand) superfamily, member 10 [Source:HGNC Symbol;Acc:11925]
nitric oxide synthase interacting protein [Source:HGNC Symbol;Acc:17946]
STEAP family member 4 [Source:HGNC Symbol;Acc:21923]
major histocompatibility complex, class II, DM beta [Source:HGNC Symbol;Acc:4935]
guanylate binding protein 5 [Source:HGNC Symbol;Acc:19895]
apolipoprotein L, 3 [Source:HGNC Symbol;Acc:14868]
IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast) [Source:HGNC Symbol;Acc:14497]
zinc finger, DHHC-type containing 16 [Source:HGNC Symbol;Acc:20714]
methylcrotonoyl-CoA carboxylase 2 (beta) [Source:HGNC Symbol;Acc:6937]
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 [Source:HGNC Symbol;Acc:10860]
eukaryotic elongation factor-2 kinase [Source:HGNC Symbol;Acc:24615]
guanylate binding protein 1, interferon-inducible [Source:HGNC Symbol;Acc:4182]
LysM, putative peptidoglycan-binding, domain containing 2 [Source:HGNC Symbol;Acc:28571]
G patch domain containing 4 [Source:HGNC Symbol;Acc:25982]
HLA complex group 18 (non-protein coding) [Source:HGNC Symbol;Acc:31337]
quiescin Q6 sulfhydryl oxidase 2 [Source:HGNC Symbol;Acc:30249]
Enah/Vasp-like [Source:HGNC Symbol;Acc:20234]
class II, major histocompatibility complex, transactivator [Source:HGNC Symbol;Acc:7067]
guanylate binding protein 4 [Source:HGNC Symbol;Acc:20480]
enoyl CoA hydratase domain containing 2 [Source:HGNC Symbol;Acc:23408]
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 [Source:HGNC Symbol;Acc:14335]
NIFK antisense RNA 1 [Source:HGNC Symbol;Acc:27385]
SLAM family member 7 [Source:HGNC Symbol;Acc:21394]
zinc finger protein 184 [Source:HGNC Symbol;Acc:12975]
zinc finger protein 720 [Source:HGNC Symbol;Acc:26987]
protein tyrosine phosphatase, receptor type, C-associated protein [Source:HGNC Symbol;Acc:9667]
transmembrane protein 194A [Source:HGNC Symbol;Acc:29001]
SET domain, bifurcated 2 [Source:HGNC Symbol;Acc:20263]
chemokine (C-X-C motif) ligand 9 [Source:HGNC Symbol;Acc:7098]
family with sequence similarity 173, member B [Source:HGNC Symbol;Acc:27029]
DAZ interacting zinc finger protein 3 [Source:HGNC Symbol;Acc:30938]
branched chain amino-acid transaminase 2, mitochondrial [Source:HGNC Symbol;Acc:977]
solute carrier family 4, sodium bicarbonate cotransporter, member 8 [Source:HGNC Symbol;Acc:11034]
CD2 molecule [Source:HGNC Symbol;Acc:1639]
lysophosphatidic acid receptor 1 [Source:HGNC Symbol;Acc:3166]
sorting nexin 25 [Source:HGNC Symbol;Acc:21883]
pleckstrin homology domain containing, family B (evectins) member 1 [Source:HGNC Symbol;Acc:19079]
transforming growth factor, beta receptor III [Source:HGNC Symbol;Acc:11774]
interferon regulatory factor 3 [Source:HGNC Symbol;Acc:6118]
membrane-spanning 4-domains, subfamily A, member 1 [Source:HGNC Symbol;Acc:7315]
1-acylglycerol-3-phosphate O-acyltransferase 5 [Source:HGNC Symbol;Acc:20886]
family with sequence similarity 169, member A [Source:HGNC Symbol;Acc:29138]
lethal giant larvae homolog 2 (Drosophila) [Source:HGNC Symbol;Acc:6629]
sphingosine-1-phosphate receptor 1 [Source:HGNC Symbol;Acc:3165]
ATPase, class V, type 10D [Source:HGNC Symbol;Acc:13549]
CD5 molecule [Source:HGNC Symbol;Acc:1685]
human immunodeficiency virus type I enhancer binding protein 2 [Source:HGNC Symbol;Acc:4921]
perforin 1 (pore forming protein) [Source:HGNC Symbol;Acc:9360]
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog [Source:HGNC Symbol;Acc:6776]
protein phosphatase, Mg2+/Mn2+ dependent, 1K [Source:HGNC Symbol;Acc:25415]
hematological and neurological expressed 1-like [Source:HGNC Symbol;Acc:14137]
lymphocyte antigen 9 [Source:HGNC Symbol;Acc:6730]
immunoglobulin kappa variable 3-20 [Source:HGNC Symbol;Acc:5817]
CD3d molecule, delta (CD3-TCR complex) [Source:HGNC Symbol;Acc:1673]
glycoprotein A33 (transmembrane) [Source:HGNC Symbol;Acc:4445]
B-cell CLL/lymphoma 2 [Source:HGNC Symbol;Acc:990]
killer cell lectin-like receptor subfamily B, member 1 [Source:HGNC Symbol;Acc:6373]
chemokine (C-C motif) receptor 3 [Source:HGNC Symbol;Acc:1604]
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides [Source:HGNC Symbol;Acc:5713]
par-6 family cell polarity regulator beta [Source:HGNC Symbol;Acc:16245]
IKAROS family zinc finger 3 (Aiolos) [Source:HGNC Symbol;Acc:13178]
interleukin 12 receptor, beta 2 [Source:HGNC Symbol;Acc:5972]
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 [Source:HGNC Symbol;Acc:13564]
immunoglobulin heavy constant mu [Source:HGNC Symbol;Acc:5541]
interleukin 24 [Source:HGNC Symbol;Acc:11346]
adenosine deaminase-like [Source:HGNC Symbol;Acc:31853]
aquaporin 3 (Gill blood group) [Source:HGNC Symbol;Acc:636]
v-ets avian erythroblastosis virus E26 oncogene homolog 1 [Source:HGNC Symbol;Acc:3488]
ectonucleotide pyrophosphatase/phosphodiesterase 3 [Source:HGNC Symbol;Acc:3358]
SLAM family member 6 [Source:HGNC Symbol;Acc:21392]
Kruppel-like factor 12 [Source:HGNC Symbol;Acc:6346]
chemokine (C-X-C motif) ligand 10 [Source:HGNC Symbol;Acc:10637]
T cell receptor gamma constant 1 [Source:HGNC Symbol;Acc:12275]
long intergenic non-protein coding RNA 861 [Source:HGNC Symbol;Acc:45133]
interleukin 7 receptor [Source:HGNC Symbol;Acc:6024]
zinc finger and SCAN domain containing 5A [Source:HGNC Symbol;Acc:23710]
purinergic receptor P2Y, G-protein coupled, 10 [Source:HGNC Symbol;Acc:19906]
A kinase (PRKA) anchor protein 12 [Source:HGNC Symbol;Acc:370]
zeta-chain (TCR) associated protein kinase 70kDa [Source:HGNC Symbol;Acc:12858]
A kinase (PRKA) anchor protein 5 [Source:HGNC Symbol;Acc:375]
carbonic anhydrase VIII [Source:HGNC Symbol;Acc:1382]
chemokine (C-C motif) receptor 7 [Source:HGNC Symbol;Acc:1608]
PAS domain containing serine/threonine kinase [Source:HGNC Symbol;Acc:17270]
KDEL (Lys-Asp-Glu-Leu) containing 2 [Source:HGNC Symbol;Acc:28496]
3'(2'), 5'-bisphosphate nucleotidase 1 [Source:HGNC Symbol;Acc:1096]
CD160 molecule [Source:HGNC Symbol;Acc:17013]
dipeptidyl-peptidase 4 [Source:HGNC Symbol;Acc:3009]
zinc finger protein 831 [Source:HGNC Symbol;Acc:16167]
T cell receptor associated transmembrane adaptor 1 [Source:HGNC Symbol;Acc:30698]
CD8a molecule [Source:HGNC Symbol;Acc:1706]
CD40 molecule, TNF receptor superfamily member 5 [Source:HGNC Symbol;Acc:11919]
patched 1 [Source:HGNC Symbol;Acc:9585]
chemokine (C-X3-C motif) receptor 1 [Source:HGNC Symbol;Acc:2558]
CD3g molecule, gamma (CD3-TCR complex) [Source:HGNC Symbol;Acc:1675]
lymphoid enhancer-binding factor 1 [Source:HGNC Symbol;Acc:6551]
protease, serine, 23 [Source:HGNC Symbol;Acc:14370]
major histocompatibility complex, class II, DO alpha [Source:HGNC Symbol;Acc:4936]
RAR-related orphan receptor A [Source:HGNC Symbol;Acc:10258]
B-cell linker [Source:HGNC Symbol;Acc:14211]
Fc receptor-like 6 [Source:HGNC Symbol;Acc:31910]
NEL-like 2 (chicken) [Source:HGNC Symbol;Acc:7751]
calcium channel, voltage-dependent, alpha 2/delta subunit 2 [Source:HGNC Symbol;Acc:1400]
B-cell CLL/lymphoma 11B (zinc finger protein) [Source:HGNC Symbol;Acc:13222]
killer cell lectin-like receptor subfamily G, member 1 [Source:HGNC Symbol;Acc:6380]
interleukin 2 receptor, beta [Source:HGNC Symbol;Acc:6009]
eomesodermin [Source:HGNC Symbol;Acc:3372]
T cell receptor beta constant 2 [Source:HGNC Symbol;Acc:12157]
lymphocyte-specific protein tyrosine kinase [Source:HGNC Symbol;Acc:6524]
granzyme H (cathepsin G-like 2, protein h-CCPX) [Source:HGNC Symbol;Acc:4710]
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide [Source:HGNC Symbol;Acc:3609]
T cell receptor alpha constant [Source:HGNC Symbol;Acc:12029]
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) [Source:HGNC Symbol;Acc:4708]
inositol polyphosphate-4-phosphatase, type II, 105kDa [Source:HGNC Symbol;Acc:6075]
nuclear receptor subfamily 3, group C, member 2 [Source:HGNC Symbol;Acc:7979]
GO Term Description P-value FDR q-value Enrichment N B n b
GO:0009605 response to external stimulus 1.28E-09 1.55E-05 3.64 11696 803 112 28
GO:0042127 regulation of cell proliferation 4.03E-09 2.43E-05 3.35 11696 903 112 29
GO:0048523 negative regulation of cellular process 6.04E-09 2.43E-05 2.07 11696 2722 112 54
GO:0051239 regulation of multicellular organismal process 1.56E-08 4.72E-05 2.66 11696 1411 112 36
GO:1901700 response to oxygen-containing compound 1.58E-08 3.83E-05 3.59 11696 727 112 25
GO:0051240 positive regulation of multicellular organismal process 1.99E-08 4.01E-05 3.43 11696 792 112 26
GO:0002682 regulation of immune system process 3.29E-08 5.68E-05 2.97 11696 1054 112 30
GO:0016477 cell migration 4.30E-08 6.50E-05 4.43 11696 448 112 19
GO:0040011 locomotion 9.12E-08 1.22E-04 3.83 11696 572 112 21
GO:0048519 negative regulation of biological process 9.99E-08 1.21E-04 1.92 11696 2939 112 54
GO:0048870 cell motility 1.41E-07 1.55E-04 4.11 11696 483 112 19
GO:0042221 response to chemical 2.20E-07 2.21E-04 2.55 11696 1351 112 33
GO:0001817 regulation of cytokine production 2.59E-07 2.41E-04 4.41 11696 403 112 17
GO:0033993 response to lipid 2.98E-07 2.58E-04 4.36 11696 407 112 17
GO:0001819 positive regulation of cytokine production 3.47E-07 2.80E-04 5.32 11696 275 112 14
GO:0010628 positive regulation of gene expression 5.76E-07 4.35E-04 2.67 11696 1133 112 29
GO:0048518 positive regulation of biological process 5.94E-07 4.22E-04 1.74 11696 3545 112 59
GO:0048522 positive regulation of cellular process 6.69E-07 4.49E-04 1.84 11696 3015 112 53
GO:0002376 immune system process 7.18E-07 4.57E-04 2.47 11696 1351 112 32
GO:0051241 negative regulation of multicellular organismal process 1.03E-06 6.21E-04 3.61 11696 550 112 19
GO:0032102 negative regulation of response to external stimulus 1.14E-06 6.54E-04 7.25 11696 144 112 10
GO:0010604 positive regulation of macromolecule metabolic process 1.30E-06 7.14E-04 2.17 11696 1832 112 38
GO:0010033 response to organic substance 1.44E-06 7.57E-04 2.69 11696 1050 112 27
GO:0006952 defense response 2.38E-06 1.20E-03 2.76 11696 946 112 25
GO:0032879 regulation of localization 2.48E-06 1.20E-03 2.34 11696 1429 112 32
GO:0044767 single-organism developmental process 3.06E-06 1.42E-03 1.89 11696 2547 112 46
GO:0009719 response to endogenous stimulus 3.21E-06 1.44E-03 3.34 11696 594 112 19
GO:0051918 negative regulation of fibrinolysis 3.40E-06 1.47E-03 78.32 11696 4 112 3
GO:0010557 positive regulation of macromolecule biosynthetic process 3.96E-06 1.65E-03 2.55 11696 1107 112 27
GO:0032502 developmental process 4.44E-06 1.79E-03 1.82 11696 2752 112 48
GO:0044699 single-organism process 4.72E-06 1.84E-03 1.31 11696 7313 112 92
GO:0002683 negative regulation of immune system process 4.84E-06 1.83E-03 4.99 11696 251 112 12
GO:0032496 response to lipopolysaccharide 5.10E-06 1.87E-03 6.14 11696 170 112 10
GO:0006955 immune response 5.82E-06 2.07E-03 2.78 11696 864 112 23
GO:2000026 regulation of multicellular organismal development 6.29E-06 2.17E-03 2.77 11696 868 112 23
GO:0043207 response to external biotic stimulus 6.82E-06 2.29E-03 3.66 11696 457 112 16
GO:0051049 regulation of transport 7.17E-06 2.34E-03 2.53 11696 1074 112 26
GO:0050710 negative regulation of cytokine secretion 7.28E-06 2.32E-03 18 11696 29 112 5
GO:0044763 single-organism cellular process 7.67E-06 2.38E-03 1.38 11696 6300 112 83
GO:0044707 single-multicellular organism process 7.89E-06 2.38E-03 2.11 11696 1736 112 35
GO:0051917 regulation of fibrinolysis 8.43E-06 2.49E-03 62.66 11696 5 112 3
GO:0008284 positive regulation of cell proliferation 8.72E-06 2.51E-03 3.59 11696 466 112 16
GO:0002237 response to molecule of bacterial origin 8.89E-06 2.50E-03 5.77 11696 181 112 10
GO:0031328 positive regulation of cellular biosynthetic process 9.04E-06 2.48E-03 2.44 11696 1157 112 27
GO:0006954 inflammatory response 9.10E-06 2.44E-03 4.69 11696 267 112 12
GO:0010646 regulation of cell communication 9.83E-06 2.58E-03 2.05 11696 1831 112 36
GO:0008285 negative regulation of cell proliferation 9.85E-06 2.53E-03 3.76 11696 417 112 15
GO PROCESS UP-REGULATED
Genes
[DDIT4  -  dna-damage-inducible transcript 4, WIPI1  -  wd repeat domain, phosphoinositide interacting 1, FOSL1  -  fos-like antigen 1, APOA2  -  apolipoprotein a-ii, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, PTGER2  -  prostaglandin e receptor 2 (subtype ep2), 53kda, SDC4  -  syndecan 4, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, NLRP3  -  nlr family, pyrin domain containing 3, BAG3  -  bcl2-associated athanogene 3, CHIT1  -  chitinase 1 
(chitotriosidase), UPP1  -  uridine phosphorylase 1, LTF  -  lactotransferrin, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, CCL4  -  chemokine (c-c motif) ligand 4, TRIM11  -  tripartite motif containing 11, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), IL10  -  interleukin 10, SDC2  -  syndecan 2, CCRN4L  -  ccr4 carbon catabolite repression 4-
like (s. cerevisiae), THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, ELANE  -  elastase, neutrophil expressed]
[ALOX15B  -  arachidonate 15-lipoxygenase, type b, FOSL1  -  fos-like antigen 1, FN1  -  fibronectin 1, EREG  -  epiregulin, HTRA1  -  htra serine peptidase 1, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, PTGER2  -  prostaglandin e receptor 2 (subtype ep2), 53kda, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RGCC  -  regulator of cell cycle, JAG1  -  jagged 1, PNP  -  purine nucleoside phosphorylase, ATF3  -  activating transcription factor 3, LTF  -  
lactotransferrin, KLF9  -  kruppel-like factor 9, ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, SOX4  -  sry (sex determining region y)-box 4, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), ASPH  -  aspartate beta-hydroxylase, AHR  -  aryl hydrocarbon receptor, PER2  -  period circadian clock 2, VSIG4  -  v-set and immunoglobulin domain 
containing 4, IL10  -  interleukin 10, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, HBEGF  -  heparin-binding egf-like growth factor, ELANE  -  elastase, neutrophil expressed]
[FN1  -  fibronectin 1, APOA2  -  apolipoprotein a-ii, HTRA1  -  htra serine peptidase 1, HMGB2  -  high mobility group box 2, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), JAG1  -  jagged 1, SAP30  -  sin3a-associated protein, 30kda, MERTK  -  c-mer proto-oncogene tyrosine kinase, ATF3  -  activating transcription factor 3, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, KLF9  -  kruppel-like factor 9, ZBTB16  -  zinc finger and btb domain containing 16, ID2  -  
inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, VIM  -  vimentin, TRIM11  -  tripartite motif containing 11, CCL4  -  chemokine (c-c motif) ligand 4, SOX4  -  sry (sex determining region y)-box 4, H2AFY  -  h2a histone family, member y, AHR  -  aryl hydrocarbon receptor, PER2  -  period circadian clock 2, ACKR3  -  atypical chemokine receptor 3, IL10  -  interleukin 10, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, 
plasminogen activator inhibitor type 1), member 1, VAT1  -  vesicle amine transport protein 1 homolog (t. californica), HBEGF  -  heparin-binding egf-like growth factor, ELANE  -  elastase, neutrophil expressed, DDIT4  -  dna-damage-inducible transcript 4, ALOX15B  -  arachidonate 15-lipoxygenase, type b, FOSL1  -  fos-like antigen 1, EREG  -  epiregulin, ADAM17  -  adam metallopeptidase domain 17, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, ACVR1B  -  activin a receptor, type ib, RGCC  -  
regulator of cell cycle, GRB10  -  growth factor receptor-bound protein 10, NLRP3  -  nlr family, pyrin domain containing 3, BAG3  -  bcl2-associated athanogene 3, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, LTF  -  lactotransferrin, MAPK7  -  mitogen-activated protein kinase 7, JDP2  -  jun dimerization protein 2, QSOX1  -  quiescin q6 sulfhydryl oxidase 1, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), ASPH  -  aspartate beta-hydroxylase, KCNE1  -  
potassium voltage-gated channel, isk-related family, member 1, C3  -  complement component 3, VSIG4  -  v-set and immunoglobulin domain containing 4, GAS2L3  -  growth arrest-specific 2 like 3, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SRGAP1  -  slit-robo rho gtpase activating protein 1, OLFM4  -  olfactomedin 4]
[IL18R1  -  interleukin 18 receptor 1, ALOX15B  -  arachidonate 15-lipoxygenase, type b, FN1  -  fibronectin 1, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, ACVR1B  -  activin a receptor, type ib, RGCC  -  regulator of cell cycle, JAG1  -  jagged 1, PNP  -  purine nucleoside phosphorylase, NLRP3  -  nlr family, pyrin domain containing 3, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, LTF  -  
lactotransferrin, ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, MAPK7  -  mitogen-activated protein kinase 7, VIM  -  vimentin, TRIM11  -  tripartite motif containing 11, ASPH  -  aspartate beta-hydroxylase, H2AFY  -  h2a histone family, member y, PER2  -  period circadian clock 2, KCNE1  -  potassium 
voltage-gated channel, isk-related family, member 1, C3  -  complement component 3, VSIG4  -  v-set and immunoglobulin domain containing 4, IL10  -  interleukin 10, SDC2  -  syndecan 2, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, HBEGF  -  heparin-binding egf-like growth 
factor, ELANE  -  elastase, neutrophil expressed]
[FOSL1  -  fos-like antigen 1, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, PTGER2  -  prostaglandin e receptor 2 (subtype ep2), 53kda, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, GRB10  -  growth factor receptor-bound protein 10, JAG1  -  jagged 1, NLRP3  -  nlr family, pyrin domain containing 3, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, KLF9  -  kruppel-like factor 9, MAPK7  -  
mitogen-activated protein kinase 7, SOX4  -  sry (sex determining region y)-box 4, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), ASPH  -  aspartate beta-hydroxylase, KCNE1  -  potassium voltage-gated channel, isk-related family, member 1, IL10  -  interleukin 10, OLR1  -  oxidized low density lipoprotein (lectin-like) receptor 1, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SERPINE1  -  serpin peptidase inhibitor, 
clade e (nexin, plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, ELANE  -  elastase, neutrophil expressed]
[IL18R1  -  interleukin 18 receptor 1, ALOX15B  -  arachidonate 15-lipoxygenase, type b, FN1  -  fibronectin 1, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, ACVR1B  -  activin a receptor, type ib, RGCC  -  regulator of cell cycle, JAG1  -  jagged 1, NLRP3  -  nlr family, pyrin domain containing 3, PNP  -  purine nucleoside phosphorylase, LTF  -  lactotransferrin, ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  
-  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, H2AFY  -  h2a histone family, member y, C3  -  complement component 3, IL10  -  interleukin 10, THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, HBEGF  -  
heparin-binding egf-like growth factor, ELANE  -  elastase, neutrophil expressed]
[EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, HTRA1  -  htra serine peptidase 1, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, ACVR1B  -  activin a receptor, type ib, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RGCC  -  regulator of cell cycle, JAG1  -  jagged 1, PNP  -  purine nucleoside phosphorylase, MERTK  -  c-mer proto-oncogene tyrosine kinase, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, LTF  -  
lactotransferrin, ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, MAPK7  -  mitogen-activated protein kinase 7, CCL4  -  chemokine (c-c motif) ligand 4, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), AHR  -  aryl hydrocarbon receptor, C3  -  complement component 3, IL10  -  interleukin 10, VSIG4  -  v-set and immunoglobulin domain containing 
4, ACKR3  -  atypical chemokine receptor 3, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, HBEGF  -  heparin-binding egf-like growth factor, OLFM4  -  olfactomedin 4, ELANE  -  elastase, neutrophil expressed]
[DDIT4  -  dna-damage-inducible transcript 4, FN1  -  fibronectin 1, CCL4  -  chemokine (c-c motif) ligand 4, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, SDC4  -  syndecan 4, IL10  -  interleukin 10, SDC2  -  syndecan 2, OLR1  -  oxidized low density lipoprotein (lectin-like) receptor 1, THBS1  -  thrombospondin 1, CD177  -  cd177 molecule, THBD  -  thrombomodulin, SRGAP1  -  slit-robo rho gtpase activating protein 1, ZFAND5  -  zinc finger, an1-type domain 5, MERTK  
-  c-mer proto-oncogene tyrosine kinase, CCL20  -  chemokine (c-c motif) ligand 20, HBEGF  -  heparin-binding egf-like growth factor, ELANE  -  elastase, neutrophil expressed, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda]
[DDIT4  -  dna-damage-inducible transcript 4, FOSL1  -  fos-like antigen 1, FN1  -  fibronectin 1, CCL4  -  chemokine (c-c motif) ligand 4, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, SDC4  -  syndecan 4, IL10  -  interleukin 10, ACKR3  -  atypical chemokine receptor 3, SDC2  -  syndecan 2, OLR1  -  oxidized low density lipoprotein (lectin-like) receptor 1, THBS1  -  thrombospondin 1, CD177  -  cd177 molecule, THBD  -  thrombomodulin, SRGAP1  -  slit-robo rho gtpase 
activating protein 1, ZFAND5  -  zinc finger, an1-type domain 5, MERTK  -  c-mer proto-oncogene tyrosine kinase, CCL20  -  chemokine (c-c motif) ligand 20, HBEGF  -  heparin-binding egf-like growth factor, ELANE  -  elastase, neutrophil expressed, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda]
[FN1  -  fibronectin 1, APOA2  -  apolipoprotein a-ii, HTRA1  -  htra serine peptidase 1, HMGB2  -  high mobility group box 2, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), JAG1  -  jagged 1, SAP30  -  sin3a-associated protein, 30kda, MERTK  -  c-mer proto-oncogene tyrosine kinase, ATF3  -  activating transcription factor 3, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, KLF9  -  kruppel-like factor 9, ZBTB16  -  zinc finger and btb domain containing 16, ID2  -  
inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, VIM  -  vimentin, TRIM11  -  tripartite motif containing 11, CCL4  -  chemokine (c-c motif) ligand 4, SOX4  -  sry (sex determining region y)-box 4, H2AFY  -  h2a histone family, member y, AHR  -  aryl hydrocarbon receptor, PER2  -  period circadian clock 2, ACKR3  -  atypical chemokine receptor 3, IL10  -  interleukin 10, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, 
plasminogen activator inhibitor type 1), member 1, VAT1  -  vesicle amine transport protein 1 homolog (t. californica), HBEGF  -  heparin-binding egf-like growth factor, ELANE  -  elastase, neutrophil expressed, DDIT4  -  dna-damage-inducible transcript 4, ALOX15B  -  arachidonate 15-lipoxygenase, type b, FOSL1  -  fos-like antigen 1, EREG  -  epiregulin, ADAM17  -  adam metallopeptidase domain 17, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, ACVR1B  -  activin a receptor, type ib, RGCC  -  
regulator of cell cycle, GRB10  -  growth factor receptor-bound protein 10, NLRP3  -  nlr family, pyrin domain containing 3, BAG3  -  bcl2-associated athanogene 3, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, LTF  -  lactotransferrin, MAPK7  -  mitogen-activated protein kinase 7, JDP2  -  jun dimerization protein 2, QSOX1  -  quiescin q6 sulfhydryl oxidase 1, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), ASPH  -  aspartate beta-hydroxylase, KCNE1  -  
potassium voltage-gated channel, isk-related family, member 1, C3  -  complement component 3, VSIG4  -  v-set and immunoglobulin domain containing 4, GAS2L3  -  growth arrest-specific 2 like 3, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SRGAP1  -  slit-robo rho gtpase activating protein 1, OLFM4  -  olfactomedin 4]
[DDIT4  -  dna-damage-inducible transcript 4, FN1  -  fibronectin 1, CCL4  -  chemokine (c-c motif) ligand 4, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, SDC4  -  syndecan 4, IL10  -  interleukin 10, SDC2  -  syndecan 2, OLR1  -  oxidized low density lipoprotein (lectin-like) receptor 1, THBS1  -  thrombospondin 1, CD177  -  cd177 molecule, THBD  -  thrombomodulin, ZFAND5  -  zinc finger, an1-type domain 5, SRGAP1  -  slit-robo rho gtpase activating protein 1, MERTK  
-  c-mer proto-oncogene tyrosine kinase, CCL20  -  chemokine (c-c motif) ligand 20, HBEGF  -  heparin-binding egf-like growth factor, ELANE  -  elastase, neutrophil expressed, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda]
[FOSL1  -  fos-like antigen 1, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, PTGER2  -  prostaglandin e receptor 2 (subtype ep2), 53kda, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RGCC  -  regulator of cell cycle, GRB10  -  growth factor receptor-bound protein 10, JAG1  -  jagged 1, PNP  -  purine nucleoside phosphorylase, NLRP3  -  nlr family, pyrin domain containing 3, KLF9  -  kruppel-like factor 9, 
CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, PLIN2  -  perilipin 2, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, MAPK7  -  mitogen-activated protein kinase 7, CCL4  -  chemokine (c-c motif) ligand 4, SOX4  -  sry (sex determining region y)-box 4, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), ASPH  -  aspartate beta-hydroxylase, AHR  -  aryl hydrocarbon receptor, KCNE1  -  potassium 
voltage-gated channel, isk-related family, member 1, IL10  -  interleukin 10, SDC2  -  syndecan 2, OLR1  -  oxidized low density lipoprotein (lectin-like) receptor 1, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, ELANE  -  elastase, neutrophil expressed]
[ALOX15B  -  arachidonate 15-lipoxygenase, type b, IL18R1  -  interleukin 18 receptor 1, FN1  -  fibronectin 1, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, ADAM17  -  adam metallopeptidase domain 17, C3  -  complement component 3, RGCC  -  regulator of cell cycle, IL10  -  interleukin 10, VSIG4  -  v-set and immunoglobulin domain containing 4, NLRP3  -  nlr family, pyrin domain containing 3, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator 
inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, LTF  -  lactotransferrin, ELANE  -  elastase, neutrophil expressed, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda]
[FOSL1  -  fos-like antigen 1, APOA2  -  apolipoprotein a-ii, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, PTGER2  -  prostaglandin e receptor 2 (subtype ep2), 53kda, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, IL10  -  interleukin 10, NLRP3  -  nlr family, pyrin domain containing 3, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), THBS1  -  thrombospondin 1, THBD  -  
thrombomodulin, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, ELANE  -  elastase, neutrophil expressed, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, KLF9  -  kruppel-like factor 9]
[IL18R1  -  interleukin 18 receptor 1, ALOX15B  -  arachidonate 15-lipoxygenase, type b, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, ADAM17  -  adam metallopeptidase domain 17, C3  -  complement component 3, RGCC  -  regulator of cell cycle, IL10  -  interleukin 10, NLRP3  -  nlr family, pyrin domain containing 3, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, ELANE  
-  elastase, neutrophil expressed, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda]
[FOSL1  -  fos-like antigen 1, FN1  -  fibronectin 1, HMGB2  -  high mobility group box 2, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), ACVR1B  -  activin a receptor, type ib, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RGCC  -  regulator of cell cycle, JAG1  -  jagged 1, NLRP3  -  nlr family, pyrin domain containing 3, ATF3  -  activating transcription factor 3, CEBPD  -  ccaat/enhancer binding protein (c/ebp), delta, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma 
oncogene homolog b, ATOH8  -  atonal homolog 8 (drosophila), LTF  -  lactotransferrin, ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, MAPK7  -  mitogen-activated protein kinase 7, VIM  -  vimentin, SOX4  -  sry (sex determining region y)-box 4, ASPH  -  aspartate beta-hydroxylase, H2AFY  -  h2a histone 
family, member y, AHR  -  aryl hydrocarbon receptor, KLF7  -  kruppel-like factor 7 (ubiquitous), C3  -  complement component 3, IL10  -  interleukin 10, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1]
[IL18R1  -  interleukin 18 receptor 1, TSPAN14  -  tetraspanin 14, FN1  -  fibronectin 1, APOA2  -  apolipoprotein a-ii, HTRA1  -  htra serine peptidase 1, HMGB2  -  high mobility group box 2, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), SDC4  -  syndecan 4, JAG1  -  jagged 1, PNP  -  purine nucleoside phosphorylase, AGFG1  -  arfgap with fg repeats 1, MERTK  -  c-mer proto-oncogene tyrosine kinase, ATF3  -  activating transcription factor 3, ATOH8  -  atonal homolog 8 
(drosophila), ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, STX1A  -  syntaxin 1a (brain), VIM  -  vimentin, TRIM11  -  tripartite motif containing 11, CCL4  -  chemokine (c-c motif) ligand 4, SOX4  -  sry (sex determining region y)-box 4, H2AFY  -  h2a histone family, member y, AHR  -  aryl hydrocarbon 
receptor, IL10  -  interleukin 10, ACKR3  -  atypical chemokine receptor 3, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FMN1  -  formin 1, HBEGF  -  heparin-binding egf-like growth factor, CCL20  -  chemokine (c-c motif) ligand 20, ELANE  -  elastase, neutrophil expressed, ALOX15B  -  arachidonate 15-lipoxygenase, type b, DDIT4  -  dna-damage-inducible transcript 4, FOSL1  -  fos-like antigen 1, EREG  -  epiregulin, ADAM17  -  adam 
metallopeptidase domain 17, ACVR1B  -  activin a receptor, type ib, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, GRB10  -  growth factor receptor-bound protein 10, RGCC  -  regulator of cell cycle, NLRP3  -  nlr family, pyrin domain containing 3, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, CEBPD  -  ccaat/enhancer binding protein (c/ebp), delta, LTF  -  lactotransferrin, JDP2  -  jun dimerization protein 2, MAPK7  -  mitogen-activated protein kinase 7, CDKN1A  -  
cyclin-dependent kinase inhibitor 1a (p21, cip1), ASPH  -  aspartate beta-hydroxylase, MFGE8  -  milk fat globule-egf factor 8 protein, KLF7  -  kruppel-like factor 7 (ubiquitous), KCNE1  -  potassium voltage-gated channel, isk-related family, member 1, C3  -  complement component 3, VSIG4  -  v-set and immunoglobulin domain containing 4, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SRGAP1  -  slit-robo rho gtpase activating 
protein 1, OLFM4  -  olfactomedin 4]
[IL18R1  -  interleukin 18 receptor 1, FN1  -  fibronectin 1, TSPAN14  -  tetraspanin 14, APOA2  -  apolipoprotein a-ii, HTRA1  -  htra serine peptidase 1, HMGB2  -  high mobility group box 2, SDC4  -  syndecan 4, JAG1  -  jagged 1, PNP  -  purine nucleoside phosphorylase, MERTK  -  c-mer proto-oncogene tyrosine kinase, ATF3  -  activating transcription factor 3, ATOH8  -  atonal homolog 8 (drosophila), CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ZBTB16  -  zinc finger and btb domain 
containing 16, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, STX1A  -  syntaxin 1a (brain), TRIM11  -  tripartite motif containing 11, CCL4  -  chemokine (c-c motif) ligand 4, SOX4  -  sry (sex determining region y)-box 4, H2AFY  -  h2a histone family, member y, AHR  -  aryl hydrocarbon receptor, ACKR3  -  atypical chemokine receptor 3, IL10  -  interleukin 10, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, 
plasminogen activator inhibitor type 1), member 1, FMN1  -  formin 1, CCL20  -  chemokine (c-c motif) ligand 20, HBEGF  -  heparin-binding egf-like growth factor, ELANE  -  elastase, neutrophil expressed, DDIT4  -  dna-damage-inducible transcript 4, ALOX15B  -  arachidonate 15-lipoxygenase, type b, FOSL1  -  fos-like antigen 1, EREG  -  epiregulin, ADAM17  -  adam metallopeptidase domain 17, ACVR1B  -  activin a receptor, type ib, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RGCC  -  
regulator of cell cycle, GRB10  -  growth factor receptor-bound protein 10, NLRP3  -  nlr family, pyrin domain containing 3, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, CEBPD  -  ccaat/enhancer binding protein (c/ebp), delta, LTF  -  lactotransferrin, MAPK7  -  mitogen-activated protein kinase 7, JDP2  -  jun dimerization protein 2, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), ASPH  -  aspartate beta-hydroxylase, MFGE8  -  milk fat globule-egf factor 8 
protein, KLF7  -  kruppel-like factor 7 (ubiquitous), KCNE1  -  potassium voltage-gated channel, isk-related family, member 1, C3  -  complement component 3, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), THBS1  -  thrombospondin 1, OLFM4  -  olfactomedin 4]
[DDIT4  -  dna-damage-inducible transcript 4, IL18R1  -  interleukin 18 receptor 1, FN1  -  fibronectin 1, EREG  -  epiregulin, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RGCC  -  regulator of cell cycle, JAG1  -  jagged 1, PNP  -  purine nucleoside phosphorylase, NLRP3  -  nlr family, pyrin domain containing 3, CHIT1  -  chitinase 1 (chitotriosidase), MERTK  -  c-mer proto-oncogene tyrosine kinase, MAFB  -  v-maf 
avian musculoaponeurotic fibrosarcoma oncogene homolog b, LTF  -  lactotransferrin, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, MAPK7  -  mitogen-activated protein kinase 7, CCL4  -  chemokine (c-c motif) ligand 4, TRIM11  -  tripartite motif containing 11, SOX4  -  sry (sex determining region y)-box 4, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), C3  -  complement component 3, IL10  -  
interleukin 10, VSIG4  -  v-set and immunoglobulin domain containing 4, OLR1  -  oxidized low density lipoprotein (lectin-like) receptor 1, THBS1  -  thrombospondin 1, CD177  -  cd177 molecule, THBD  -  thrombomodulin, CCL20  -  chemokine (c-c motif) ligand 20, HBEGF  -  heparin-binding egf-like growth factor, ELANE  -  elastase, neutrophil expressed]
[ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, FN1  -  fibronectin 1, APOA2  -  apolipoprotein a-ii, VIM  -  vimentin, TRIM11  -  tripartite motif containing 11, RGCC  -  regulator of cell cycle, IL10  -  interleukin 10, VSIG4  -  v-set and immunoglobulin domain containing 4, JAG1  -  jagged 1, NLRP3  -  nlr family, pyrin domain containing 3, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SERPINE1  -  serpin 
peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, LTF  -  lactotransferrin, ELANE  -  elastase, neutrophil expressed, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ZBTB16  -  zinc finger and btb domain containing 16]
[IL10  -  interleukin 10, MAPK7  -  mitogen-activated protein kinase 7, NLRP3  -  nlr family, pyrin domain containing 3, THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, QSOX1  -  quiescin q6 sulfhydryl oxidase 1, HTRA1  -  htra serine peptidase 1, LTF  -  lactotransferrin, ELANE  -  elastase, neutrophil expressed]
[FOSL1  -  fos-like antigen 1, FN1  -  fibronectin 1, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, ACVR1B  -  activin a receptor, type ib, SDC4  -  syndecan 4, RGCC  -  regulator of cell cycle, JAG1  -  jagged 1, NLRP3  -  nlr family, pyrin domain containing 3, ATF3  -  activating transcription 
factor 3, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, CEBPD  -  ccaat/enhancer binding protein (c/ebp), delta, LTF  -  lactotransferrin, ATOH8  -  atonal homolog 8 (drosophila), ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, JDP2  -  jun dimerization protein 2, MAPK7  -  
mitogen-activated protein kinase 7, VIM  -  vimentin, SOX4  -  sry (sex determining region y)-box 4, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), H2AFY  -  h2a histone family, member y, ASPH  -  aspartate beta-hydroxylase, AHR  -  aryl hydrocarbon receptor, KLF7  -  kruppel-like factor 7 (ubiquitous), C3  -  complement component 3, IL10  -  interleukin 10, ACKR3  -  atypical chemokine receptor 3, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, 
plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, ELANE  -  elastase, neutrophil expressed]
[FOSL1  -  fos-like antigen 1, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, PTGER2  -  prostaglandin e receptor 2 (subtype ep2), 53kda, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, GRB10  -  growth factor receptor-bound protein 10, JAG1  -  jagged 1, NLRP3  -  nlr family, pyrin domain containing 3, KLF9  -  kruppel-like factor 9, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, PLIN2  -  
perilipin 2, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, MAPK7  -  mitogen-activated protein kinase 7, SOX4  -  sry (sex determining region y)-box 4, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), ASPH  -  aspartate beta-hydroxylase, KCNE1  -  potassium voltage-gated channel, isk-related family, member 1, IL10  -  interleukin 10, SDC2  -  syndecan 2, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SERPINE1  
-  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, ELANE  -  elastase, neutrophil expressed]
[DDIT4  -  dna-damage-inducible transcript 4, FOSL1  -  fos-like antigen 1, FN1  -  fibronectin 1, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, NLRP3  -  nlr family, pyrin domain containing 3, LTF  -  lactotransferrin, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, MAPK7  -  mitogen-activated protein kinase 7, CCL4  -  chemokine (c-c motif) ligand 
4, TRIM11  -  tripartite motif containing 11, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), C3  -  complement component 3, IL10  -  interleukin 10, VSIG4  -  v-set and immunoglobulin domain containing 4, OLR1  -  oxidized low density lipoprotein (lectin-like) receptor 1, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, HBEGF  -  heparin-binding egf-like growth 
factor, ELANE  -  elastase, neutrophil expressed, TPST1  -  tyrosylprotein sulfotransferase 1]
[SYN1  -  synapsin i, IL18R1  -  interleukin 18 receptor 1, ALOX15B  -  arachidonate 15-lipoxygenase, type b, FN1  -  fibronectin 1, APOA2  -  apolipoprotein a-ii, ADAM17  -  adam metallopeptidase domain 17, ACVR1B  -  activin a receptor, type ib, SDC4  -  syndecan 4, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RGCC  -  regulator of cell cycle, GRB10  -  growth factor receptor-bound protein 10, JAG1  -  jagged 1, NLRP3  -  nlr family, pyrin domain containing 3, MERTK  -  c-mer proto-oncogene 
tyrosine kinase, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, MAPK7  -  mitogen-activated protein kinase 7, STX1A  -  syntaxin 1a (brain), CCL4  -  chemokine (c-c motif) ligand 4, SOX4  -  sry (sex determining region y)-box 4, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), ASPH  -  aspartate beta-hydroxylase, MFGE8  -  milk fat globule-egf factor 8 protein, PER2  -  period circadian clock 2, KCNE1  -  potassium voltage-
gated channel, isk-related family, member 1, C3  -  complement component 3, IL10  -  interleukin 10, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, SRGAP1  -  slit-robo rho gtpase activating protein 1, HBEGF  -  heparin-binding egf-like growth factor, CCL20  -  chemokine (c-c motif) ligand 20]
[IL18R1  -  interleukin 18 receptor 1, ALOX15B  -  arachidonate 15-lipoxygenase, type b, DDIT4  -  dna-damage-inducible transcript 4, ADAMTS2  -  adam metallopeptidase with thrombospondin type 1 motif, 2, FOSL1  -  fos-like antigen 1, FN1  -  fibronectin 1, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, HTRA1  -  htra serine peptidase 1, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), 
ACVR1B  -  activin a receptor, type ib, JAG1  -  jagged 1, FLNB  -  filamin b, beta, BAG3  -  bcl2-associated athanogene 3, SAP30  -  sin3a-associated protein, 30kda, AGFG1  -  arfgap with fg repeats 1, MERTK  -  c-mer proto-oncogene tyrosine kinase, ATF3  -  activating transcription factor 3, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, LTF  -  lactotransferrin, ATOH8  -  atonal homolog 8 (drosophila), ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin 
(cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, MAPK7  -  mitogen-activated protein kinase 7, VIM  -  vimentin, SOX4  -  sry (sex determining region y)-box 4, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), MMP8  -  matrix metallopeptidase 8 (neutrophil collagenase), ASPH  -  aspartate beta-hydroxylase, MFGE8  -  milk fat globule-egf factor 8 protein, AHR  -  aryl 
hydrocarbon receptor, KLF7  -  kruppel-like factor 7 (ubiquitous), PER2  -  period circadian clock 2, SEMA6B  -  sema domain, transmembrane domain (tm), and cytoplasmic domain, (semaphorin) 6b, IL10  -  interleukin 10, ACKR3  -  atypical chemokine receptor 3, SDC2  -  syndecan 2, ARL4A  -  adp-ribosylation factor-like 4a, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, ZFAND5  -  zinc finger, an1-type domain 5, 
HBEGF  -  heparin-binding egf-like growth factor]
[FOSL1  -  fos-like antigen 1, MAPK7  -  mitogen-activated protein kinase 7, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, ASPH  -  aspartate beta-hydroxylase, PTGER2  -  prostaglandin e receptor 2 (subtype ep2), 53kda, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, KCNE1  -  potassium voltage-gated channel, isk-related family, member 1, GRB10  -  
growth factor receptor-bound protein 10, IL10  -  interleukin 10, SDC2  -  syndecan 2, JAG1  -  jagged 1, THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, KLF9  -  kruppel-like factor 9]
[THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1]
[FOSL1  -  fos-like antigen 1, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, HMGB2  -  high mobility group box 2, ACVR1B  -  activin a receptor, type ib, RGCC  -  regulator of cell cycle, JAG1  -  jagged 1, NLRP3  -  nlr family, pyrin domain containing 3, ATF3  -  activating transcription factor 3, CEBPD  -  ccaat/enhancer binding protein (c/ebp), delta, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, ATOH8  -  atonal homolog 8 (drosophila), LTF  -  lactotransferrin, ZBTB16  -  
zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, MAPK7  -  mitogen-activated protein kinase 7, SOX4  -  sry (sex determining region y)-box 4, ASPH  -  aspartate beta-hydroxylase, AHR  -  aryl hydrocarbon receptor, KLF7  -  kruppel-like factor 7 (ubiquitous), IL10  -  interleukin 10, THBS1  -  thrombospondin 1, 
SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, ELANE  -  elastase, neutrophil expressed]
[IL18R1  -  interleukin 18 receptor 1, ALOX15B  -  arachidonate 15-lipoxygenase, type b, DDIT4  -  dna-damage-inducible transcript 4, ADAMTS2  -  adam metallopeptidase with thrombospondin type 1 motif, 2, FOSL1  -  fos-like antigen 1, FN1  -  fibronectin 1, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, HTRA1  -  htra serine peptidase 1, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), 
ACVR1B  -  activin a receptor, type ib, SDC4  -  syndecan 4, JAG1  -  jagged 1, FLNB  -  filamin b, beta, BAG3  -  bcl2-associated athanogene 3, AGFG1  -  arfgap with fg repeats 1, SAP30  -  sin3a-associated protein, 30kda, MERTK  -  c-mer proto-oncogene tyrosine kinase, ATF3  -  activating transcription factor 3, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, LTF  -  lactotransferrin, ATOH8  -  atonal homolog 8 (drosophila), ZBTB16  -  zinc finger and btb domain containing 16, 
CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, MAPK7  -  mitogen-activated protein kinase 7, VIM  -  vimentin, CPM  -  carboxypeptidase m, SOX4  -  sry (sex determining region y)-box 4, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), MMP8  -  matrix metallopeptidase 8 (neutrophil collagenase), ASPH  -  aspartate beta-hydroxylase, MFGE8  -  
milk fat globule-egf factor 8 protein, AHR  -  aryl hydrocarbon receptor, KLF7  -  kruppel-like factor 7 (ubiquitous), PER2  -  period circadian clock 2, SEMA6B  -  sema domain, transmembrane domain (tm), and cytoplasmic domain, (semaphorin) 6b, IL10  -  interleukin 10, ACKR3  -  atypical chemokine receptor 3, SDC2  -  syndecan 2, ARL4A  -  adp-ribosylation factor-like 4a, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 
1, ZFAND5  -  zinc finger, an1-type domain 5, HBEGF  -  heparin-binding egf-like growth factor]
[TEX2  -  testis expressed 2, SYN1  -  synapsin i, GFOD1  -  glucose-fructose oxidoreductase domain containing 1, OLAH  -  oleoyl-acp hydrolase, IL18R1  -  interleukin 18 receptor 1, WIPI1  -  wd repeat domain, phosphoinositide interacting 1, FN1  -  fibronectin 1, APOA2  -  apolipoprotein a-ii, HTRA1  -  htra serine peptidase 1, HMGB2  -  high mobility group box 2, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), SDC4  -  syndecan 4, JAG1  -  jagged 1, FLNB  -  filamin b, beta, PNP  -  
purine nucleoside phosphorylase, MKI67  -  antigen identified by monoclonal antibody ki-67, SAP30  -  sin3a-associated protein, 30kda, AGFG1  -  arfgap with fg repeats 1, MAOA  -  monoamine oxidase a, MERTK  -  c-mer proto-oncogene tyrosine kinase, UPP1  -  uridine phosphorylase 1, ATF3  -  activating transcription factor 3, SLC36A1  -  solute carrier family 36 (proton/amino acid symporter), member 1, ATOH8  -  atonal homolog 8 (drosophila), ZBTB16  -  zinc finger and btb domain containing 16, 
CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, KLF9  -  kruppel-like factor 9, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, CORO2A  -  coronin, actin binding protein, 2a, STX1A  -  syntaxin 1a (brain), MTHFD1L  -  methylenetetrahydrofolate dehydrogenase (nadp+ dependent) 1-like, VIM  -  vimentin, FLVCR2  -  feline leukemia virus subgroup c cellular receptor family, member 2, CCL4  -  chemokine (c-c 
motif) ligand 4, SOX4  -  sry (sex determining region y)-box 4, MMP8  -  matrix metallopeptidase 8 (neutrophil collagenase), AHR  -  aryl hydrocarbon receptor, SEMA6B  -  sema domain, transmembrane domain (tm), and cytoplasmic domain, (semaphorin) 6b, PER2  -  period circadian clock 2, B4GALT4  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 4, ACKR3  -  atypical chemokine receptor 3, IL10  -  interleukin 10, SDC2  -  syndecan 2, OLR1  -  oxidized low density lipoprotein (lectin-
like) receptor 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, VAT1  -  vesicle amine transport protein 1 homolog (t. californica), FMN1  -  formin 1, CCL20  -  chemokine (c-c motif) ligand 20, HBEGF  -  heparin-binding egf-like growth factor, F5  -  coagulation factor v (proaccelerin, labile factor), ELANE  -  elastase, neutrophil expressed, DDIT4  -  dna-damage-inducible transcript 4, ALOX15B  -  arachidonate 15-lipoxygenase, type b, 
CSGALNACT2  -  chondroitin sulfate n-acetylgalactosaminyltransferase 2, ADAMTS2  -  adam metallopeptidase with thrombospondin type 1 motif, 2, FOSL1  -  fos-like antigen 1, EREG  -  epiregulin, PLBD1  -  phospholipase b domain containing 1, ADAM17  -  adam metallopeptidase domain 17, ACVR1B  -  activin a receptor, type ib, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RGCC  -  regulator of cell cycle, NLRP3  -  nlr family, pyrin domain containing 3, BAG3  -  bcl2-associated athanogene 3, 
TUBB6  -  tubulin, beta 6 class v, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, LTF  -  lactotransferrin, PLIN2  -  perilipin 2, SLC35E4  -  solute carrier family 35, member e4, MAPK7  -  mitogen-activated protein kinase 7, CH25H  -  cholesterol 25-hydroxylase, QSOX1  -  quiescin q6 sulfhydryl oxidase 1, AMPH  -  amphiphysin, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), ASPH  -  aspartate beta-hydroxylase, MFGE8  -  milk fat globule-egf factor 8 protein, 
SPIN4  -  spindlin family, member 4, KLF7  -  kruppel-like factor 7 (ubiquitous), KCNE1  -  potassium voltage-gated channel, isk-related family, member 1, C3  -  complement component 3, VSIG4  -  v-set and immunoglobulin domain containing 4, GAS2L3  -  growth arrest-specific 2 like 3, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), CD177  -  cd177 molecule, ARL4A  -  adp-ribosylation factor-like 4a, THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SLC19A2  -  solute carrier 
family 19 (thiamine transporter), member 2, SRGAP1  -  slit-robo rho gtpase activating protein 1, ZFAND5  -  zinc finger, an1-type domain 5, BCAT1  -  branched chain amino-acid transaminase 1, cytosolic]
[ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, VSIG4  -  v-set and immunoglobulin domain containing 4, IL10  -  interleukin 10, THBS1  -  thrombospondin 1, APOA2  -  apolipoprotein a-ii, HTRA1  -  htra serine peptidase 1, MERTK  -  c-mer proto-oncogene tyrosine kinase, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, LTF  -  lactotransferrin, OLFM4  -  olfactomedin 4, ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin 
(cadherin-associated protein), beta 1, 88kda]
[IL10  -  interleukin 10, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), NLRP3  -  nlr family, pyrin domain containing 3, THBD  -  thrombomodulin, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, CCL20  -  chemokine (c-c motif) ligand 20, PTGER2  -  prostaglandin e receptor 2 (subtype ep2), 53kda, ELANE  -  elastase, neutrophil expressed]
[IL18R1  -  interleukin 18 receptor 1, MAPK7  -  mitogen-activated protein kinase 7, EREG  -  epiregulin, TRIM11  -  tripartite motif containing 11, CCL4  -  chemokine (c-c motif) ligand 4, HMGB2  -  high mobility group box 2, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), ADAM17  -  adam metallopeptidase domain 17, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RGCC  -  regulator of cell cycle, C3  -  complement component 3, VSIG4  -  v-set and immunoglobulin domain containing 
4, IL10  -  interleukin 10, JAG1  -  jagged 1, PNP  -  purine nucleoside phosphorylase, NLRP3  -  nlr family, pyrin domain containing 3, THBS1  -  thrombospondin 1, CHIT1  -  chitinase 1 (chitotriosidase), HBEGF  -  heparin-binding egf-like growth factor, CCL20  -  chemokine (c-c motif) ligand 20, ELANE  -  elastase, neutrophil expressed, LTF  -  lactotransferrin, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda]
[ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, ALOX15B  -  arachidonate 15-lipoxygenase, type b, MAPK7  -  mitogen-activated protein kinase 7, FN1  -  fibronectin 1, VIM  -  vimentin, TRIM11  -  tripartite motif containing 11, HMGB2  -  high mobility group box 2, H2AFY  -  h2a histone family, member y, ACVR1B  -  activin a receptor, type ib, PER2  -  period circadian clock 2, RGCC  -  regulator of cell cycle, C3  -  complement component 3, IL10  -  interleukin 10, SDC2  -  
syndecan 2, JAG1  -  jagged 1, PNP  -  purine nucleoside phosphorylase, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, LTF  -  lactotransferrin, ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda]
[DDIT4  -  dna-damage-inducible transcript 4, FOSL1  -  fos-like antigen 1, CCL4  -  chemokine (c-c motif) ligand 4, TRIM11  -  tripartite motif containing 11, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, PTGER2  -  prostaglandin e receptor 2 (subtype ep2), 53kda, IL10  -  interleukin 10, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), NLRP3  -  nlr family, pyrin domain containing 3, THBD  -  thrombomodulin, CHIT1  -  chitinase 1 (chitotriosidase), 
SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, LTF  -  lactotransferrin, ELANE  -  elastase, neutrophil expressed]
[SYN1  -  synapsin i, IL18R1  -  interleukin 18 receptor 1, ALOX15B  -  arachidonate 15-lipoxygenase, type b, FN1  -  fibronectin 1, APOA2  -  apolipoprotein a-ii, SDC4  -  syndecan 4, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, GRB10  -  growth factor receptor-bound protein 10, RGCC  -  regulator of cell cycle, NLRP3  -  nlr family, pyrin domain containing 3, MERTK  -  c-mer proto-oncogene tyrosine kinase, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, P2RY1  -  purinergic 
receptor p2y, g-protein coupled, 1, MAPK7  -  mitogen-activated protein kinase 7, STX1A  -  syntaxin 1a (brain), CCL4  -  chemokine (c-c motif) ligand 4, SOX4  -  sry (sex determining region y)-box 4, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), ASPH  -  aspartate beta-hydroxylase, MFGE8  -  milk fat globule-egf factor 8 protein, PER2  -  period circadian clock 2, KCNE1  -  potassium voltage-gated channel, isk-related family, member 1, C3  -  complement component 3, IL10  -  interleukin 10, 
THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1]
[RGCC  -  regulator of cell cycle, IL10  -  interleukin 10, NLRP3  -  nlr family, pyrin domain containing 3, FN1  -  fibronectin 1, APOA2  -  apolipoprotein a-ii]
[TEX2  -  testis expressed 2, SYN1  -  synapsin i, OLAH  -  oleoyl-acp hydrolase, IL18R1  -  interleukin 18 receptor 1, WIPI1  -  wd repeat domain, phosphoinositide interacting 1, FN1  -  fibronectin 1, APOA2  -  apolipoprotein a-ii, HMGB2  -  high mobility group box 2, SDC4  -  syndecan 4, JAG1  -  jagged 1, FLNB  -  filamin b, beta, PNP  -  purine nucleoside phosphorylase, MKI67  -  antigen identified by monoclonal antibody ki-67, SAP30  -  sin3a-associated protein, 30kda, AGFG1  -  arfgap with fg repeats 1, 
MAOA  -  monoamine oxidase a, MERTK  -  c-mer proto-oncogene tyrosine kinase, ATF3  -  activating transcription factor 3, UPP1  -  uridine phosphorylase 1, SLC36A1  -  solute carrier family 36 (proton/amino acid symporter), member 1, ATOH8  -  atonal homolog 8 (drosophila), ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor 
p2y, g-protein coupled, 1, CORO2A  -  coronin, actin binding protein, 2a, STX1A  -  syntaxin 1a (brain), MTHFD1L  -  methylenetetrahydrofolate dehydrogenase (nadp+ dependent) 1-like, VIM  -  vimentin, FLVCR2  -  feline leukemia virus subgroup c cellular receptor family, member 2, CCL4  -  chemokine (c-c motif) ligand 4, SOX4  -  sry (sex determining region y)-box 4, MMP8  -  matrix metallopeptidase 8 (neutrophil collagenase), AHR  -  aryl hydrocarbon receptor, SEMA6B  -  sema domain, transmembrane 
domain (tm), and cytoplasmic domain, (semaphorin) 6b, PER2  -  period circadian clock 2, B4GALT4  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 4, ACKR3  -  atypical chemokine receptor 3, IL10  -  interleukin 10, SDC2  -  syndecan 2, OLR1  -  oxidized low density lipoprotein (lectin-like) receptor 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FMN1  -  formin 1, HBEGF  -  heparin-binding egf-like growth factor, CCL20  -  
chemokine (c-c motif) ligand 20, F5  -  coagulation factor v (proaccelerin, labile factor), ELANE  -  elastase, neutrophil expressed, DDIT4  -  dna-damage-inducible transcript 4, ALOX15B  -  arachidonate 15-lipoxygenase, type b, CSGALNACT2  -  chondroitin sulfate n-acetylgalactosaminyltransferase 2, ADAMTS2  -  adam metallopeptidase with thrombospondin type 1 motif, 2, FOSL1  -  fos-like antigen 1, EREG  -  epiregulin, PLBD1  -  phospholipase b domain containing 1, ADAM17  -  adam 
metallopeptidase domain 17, ACVR1B  -  activin a receptor, type ib, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RGCC  -  regulator of cell cycle, NLRP3  -  nlr family, pyrin domain containing 3, TUBB6  -  tubulin, beta 6 class v, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, LTF  -  lactotransferrin, PLIN2  -  perilipin 2, SLC35E4  -  solute carrier family 35, member e4, MAPK7  -  mitogen-activated protein kinase 7, CH25H  -  cholesterol 25-hydroxylase, QSOX1  -  
quiescin q6 sulfhydryl oxidase 1, AMPH  -  amphiphysin, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), ASPH  -  aspartate beta-hydroxylase, MFGE8  -  milk fat globule-egf factor 8 protein, KLF7  -  kruppel-like factor 7 (ubiquitous), KCNE1  -  potassium voltage-gated channel, isk-related family, member 1, C3  -  complement component 3, GAS2L3  -  growth arrest-specific 2 like 3, CD177  -  cd177 molecule, ARL4A  -  adp-ribosylation factor-like 4a, THBS1  -  thrombospondin 1, THBD  -  
thrombomodulin, SLC19A2  -  solute carrier family 19 (thiamine transporter), member 2, SRGAP1  -  slit-robo rho gtpase activating protein 1, ZFAND5  -  zinc finger, an1-type domain 5, BCAT1  -  branched chain amino-acid transaminase 1, cytosolic]
[ADAMTS2  -  adam metallopeptidase with thrombospondin type 1 motif, 2, FOSL1  -  fos-like antigen 1, FN1  -  fibronectin 1, APOA2  -  apolipoprotein a-ii, ADAM17  -  adam metallopeptidase domain 17, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), ACVR1B  -  activin a receptor, type ib, RGCC  -  regulator of cell cycle, JAG1  -  jagged 1, NLRP3  -  nlr family, pyrin domain containing 3, AGFG1  -  arfgap with fg repeats 1, MERTK  -  c-mer proto-oncogene tyrosine kinase, MAFB  -  
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, LTF  -  lactotransferrin, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ZBTB16  -  zinc finger and btb domain containing 16, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, SOX4  -  sry (sex determining region y)-box 4, AMPH  -  amphiphysin, MMP8  -  matrix metallopeptidase 8 (neutrophil collagenase), ASPH  -  aspartate beta-
hydroxylase, AHR  -  aryl hydrocarbon receptor, KCNE1  -  potassium voltage-gated channel, isk-related family, member 1, PER2  -  period circadian clock 2, IL10  -  interleukin 10, OLR1  -  oxidized low density lipoprotein (lectin-like) receptor 1, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), CD177  -  cd177 molecule, THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, 
ZFAND5  -  zinc finger, an1-type domain 5, F5  -  coagulation factor v (proaccelerin, labile factor), ELANE  -  elastase, neutrophil expressed]
[THBS1  -  thrombospondin 1, THBD  -  thrombomodulin, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1]
[ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, FOSL1  -  fos-like antigen 1, FN1  -  fibronectin 1, EREG  -  epiregulin, HTRA1  -  htra serine peptidase 1, SOX4  -  sry (sex determining region y)-box 4, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, PNP  -  purine nucleoside phosphorylase, ATF3  -  activating transcription factor 
3, HBEGF  -  heparin-binding egf-like growth factor, LTF  -  lactotransferrin, ELANE  -  elastase, neutrophil expressed, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda]
[IL10  -  interleukin 10, CCRN4L  -  ccr4 carbon catabolite repression 4-like (s. cerevisiae), NLRP3  -  nlr family, pyrin domain containing 3, THBD  -  thrombomodulin, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, CCL20  -  chemokine (c-c motif) ligand 20, PTGER2  -  prostaglandin e receptor 2 (subtype ep2), 53kda, ELANE  -  elastase, neutrophil expressed]
[FOSL1  -  fos-like antigen 1, EREG  -  epiregulin, APOA2  -  apolipoprotein a-ii, HMGB2  -  high mobility group box 2, ACVR1B  -  activin a receptor, type ib, RGCC  -  regulator of cell cycle, JAG1  -  jagged 1, NLRP3  -  nlr family, pyrin domain containing 3, ATF3  -  activating transcription factor 3, CEBPD  -  ccaat/enhancer binding protein (c/ebp), delta, MAFB  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog b, ATOH8  -  atonal homolog 8 (drosophila), LTF  -  lactotransferrin, ZBTB16  -  
zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, MAPK7  -  mitogen-activated protein kinase 7, SOX4  -  sry (sex determining region y)-box 4, ASPH  -  aspartate beta-hydroxylase, AHR  -  aryl hydrocarbon receptor, KLF7  -  kruppel-like factor 7 (ubiquitous), IL10  -  interleukin 10, THBS1  -  thrombospondin 1, 
SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CCL20  -  chemokine (c-c motif) ligand 20, ELANE  -  elastase, neutrophil expressed]
[C3  -  complement component 3, IL10  -  interleukin 10, OLR1  -  oxidized low density lipoprotein (lectin-like) receptor 1, NLRP3  -  nlr family, pyrin domain containing 3, FN1  -  fibronectin 1, THBS1  -  thrombospondin 1, APOA2  -  apolipoprotein a-ii, CCL4  -  chemokine (c-c motif) ligand 4, HMGB2  -  high mobility group box 2, CCL20  -  chemokine (c-c motif) ligand 20, ELANE  -  elastase, neutrophil expressed, TPST1  -  tyrosylprotein sulfotransferase 1]
[SYN1  -  synapsin i, IL18R1  -  interleukin 18 receptor 1, DDIT4  -  dna-damage-inducible transcript 4, ALOX15B  -  arachidonate 15-lipoxygenase, type b, TSPAN14  -  tetraspanin 14, FN1  -  fibronectin 1, EREG  -  epiregulin, HTRA1  -  htra serine peptidase 1, HMGB2  -  high mobility group box 2, ADAM17  -  adam metallopeptidase domain 17, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, ACVR1B  -  activin a receptor, type ib, 
GRB10  -  growth factor receptor-bound protein 10, JAG1  -  jagged 1, NLRP3  -  nlr family, pyrin domain containing 3, ATF3  -  activating transcription factor 3, LTF  -  lactotransferrin, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, P2RY1  -  purinergic receptor p2y, g-protein coupled, 1, MAPK7  -  mitogen-activated protein kinase 7, STX1A  -  syntaxin 1a (brain), QSOX1  -  quiescin q6 sulfhydryl oxidase 1, CCL4  -  chemokine (c-c motif) ligand 4, SOX4  -  sry (sex determining region y)-box 4, 
ASPH  -  aspartate beta-hydroxylase, PER2  -  period circadian clock 2, C3  -  complement component 3, IL10  -  interleukin 10, ACKR3  -  atypical chemokine receptor 3, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, SRGAP1  -  slit-robo rho gtpase activating protein 1, HBEGF  -  heparin-binding egf-like growth factor, OLFM4  -  olfactomedin 4, ELANE  -  elastase, neutrophil expressed]
[ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, ALOX15B  -  arachidonate 15-lipoxygenase, type b, FOSL1  -  fos-like antigen 1, EREG  -  epiregulin, SOX4  -  sry (sex determining region y)-box 4, CDKN1A  -  cyclin-dependent kinase inhibitor 1a (p21, cip1), ASPH  -  aspartate beta-hydroxylase, PER2  -  period circadian clock 2, RGCC  -  regulator of cell cycle, VSIG4  -  v-set and immunoglobulin domain containing 4, IL10  -  interleukin 10, THBS1  -  thrombospondin 1, CTNNB1  -  
catenin (cadherin-associated protein), beta 1, 88kda, ZBTB16  -  zinc finger and btb domain containing 16, KLF9  -  kruppel-like factor 9]
GO Term Description P-value FDR q-value Enrichment N B n
GO:0002376 immune system process 7.47E-15 9.03E-11 3.36 11696 1351 121
GO:0046649 lymphocyte activation 9.64E-11 5.83E-07 6.9 11696 252 121
GO:0045321 leukocyte activation 3.07E-10 1.24E-06 6 11696 306 121
GO:0006955 immune response 5.28E-10 1.60E-06 3.47 11696 864 121
GO:0002694 regulation of leukocyte activation 4.33E-09 1.05E-05 5.45 11696 319 121
GO:0050865 regulation of cell activation 9.34E-09 1.88E-05 5.19 11696 335 121
GO:0070489 T cell aggregation 1.15E-08 1.98E-05 7.76 11696 162 121
GO:0042110 T cell activation 1.15E-08 1.74E-05 7.76 11696 162 121
GO:0071593 lymphocyte aggregation 1.33E-08 1.79E-05 7.66 11696 164 121
GO:0030217 T cell differentiation 1.57E-08 1.90E-05 11.37 11696 85 121
GO:0002682 regulation of immune system process 1.61E-08 1.77E-05 2.93 11696 1054 121
GO:0070486 leukocyte aggregation 1.91E-08 1.93E-05 7.44 11696 169 121
GO:0051249 regulation of lymphocyte activation 2.57E-08 2.39E-05 5.56 11696 278 121
GO:0002696 positive regulation of leukocyte activation 3.27E-08 2.83E-05 6.44 11696 210 121
GO:0050867 positive regulation of cell activation 4.95E-08 3.99E-05 6.24 11696 217 121
GO:0001775 cell activation 5.93E-08 4.48E-05 4.14 11696 467 121
GO:0007159 leukocyte cell-cell adhesion 8.20E-08 5.83E-05 6.58 11696 191 121
GO:0007166 cell surface receptor signaling pathway 1.22E-07 8.18E-05 2.32 11696 1669 121
GO:0030098 lymphocyte differentiation 1.50E-07 9.57E-05 7.82 11696 136 121
GO:0006968 cellular defense response 1.79E-07 1.08E-04 16.5 11696 41 121
GO:0034109 homotypic cell-cell adhesion 2.10E-07 1.21E-04 6.07 11696 207 121
GO:0002684 positive regulation of immune system process 4.25E-07 2.33E-04 3.26 11696 683 121
GO:0051251 positive regulation of lymphocyte activation 7.05E-07 3.71E-04 6.01 11696 193 121
GO:0002521 leukocyte differentiation 7.87E-07 3.96E-04 5.95 11696 195 121
GO:0006952 defense response 9.55E-07 4.62E-04 2.76 11696 946 121
GO:0030155 regulation of cell adhesion 1.05E-06 4.90E-04 4 11696 411 121
GO:0007165 signal transduction 1.14E-06 5.10E-04 1.81 11696 2882 121
GO:0051239 regulation of multicellular organismal process 1.38E-06 5.95E-04 2.33 11696 1411 121
GO:0042100 B cell proliferation 1.49E-06 6.23E-04 24.17 11696 20 121
GO:0002252 immune effector process 1.81E-06 7.30E-04 4.33 11696 335 121
GO:0072676 lymphocyte migration 3.96E-06 1.54E-03 20.14 11696 24 121
GO:1902533 positive regulation of intracellular signal transduction 4.43E-06 1.68E-03 3.28 11696 560 121
GO:0098542 defense response to other organism 4.64E-06 1.70E-03 5.02 11696 231 121
GO:0022409 positive regulation of cell-cell adhesion 7.42E-06 2.64E-03 5.89 11696 164 121
GO:0042113 B cell activation 7.52E-06 2.60E-03 7.89 11696 98 121
GO:0045595 regulation of cell differentiation 7.62E-06 2.56E-03 2.67 11696 869 121
GO:0045785 positive regulation of cell adhesion 8.83E-06 2.89E-03 4.72 11696 246 121
GO:0016337 single organismal cell-cell adhesion 9.50E-06 3.02E-03 4.32 11696 291 121











































[IGHM  -  immunoglobulin heavy constant mu, CCR7  -  chemokine (c-c motif) receptor 7, IGJ  -  immunoglobulin j polypeptide, linker protein for immunoglobulin alpha and mu polypeptides, PLEKHA1  -  pleckstrin homology domain containing, family a (phosphoinositide binding specific) member 1, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), 
CIITA  -  class ii, major histocompatibility complex, transactivator, PRF1  -  perforin 1 (pore forming protein), KLRG1  -  killer cell lectin-like receptor subfamily g, member 1, TRAT1  -  t cell receptor associated transmembrane adaptor 1, IGKV3-20  -  immunoglobulin kappa variable 3-20, CXCL9  -  chemokine (c-x-c motif) ligand 9, BLNK  -  b-cell linker, ST6GAL1  -  
st6 beta-galactosamide alpha-2,6-sialyltranferase 1, ENPP3  -  ectonucleotide pyrophosphatase/phosphodiesterase 3, CD8A  -  cd8a molecule, DPP4  -  dipeptidyl-peptidase 4, IKZF3  -  ikaros family zinc finger 3 (aiolos), ATM  -  ataxia telangiectasia mutated, EOMES  -  eomesodermin, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), TNFSF10  -  tumor 
necrosis factor (ligand) superfamily, member 10, CD2  -  cd2 molecule, ETS1  -  v-ets avian erythroblastosis virus e26 oncogene homolog 1, CD3D  -  cd3d molecule, delta (cd3-tcr complex), CD5  -  cd5 molecule, RORA  -  rar-related orphan receptor a, TRAC  -  t cell receptor alpha constant, LCK  -  lymphocyte-specific protein tyrosine kinase, SLAMF7  -  slam 
family member 7, CXCL10  -  chemokine (c-x-c motif) ligand 10, HLA-DMB  -  major histocompatibility complex, class ii, dm beta, CD40  -  cd40 molecule, tnf receptor superfamily member 5, GBP1  -  guanylate binding protein 1, interferon-inducible, HLA-DOA  -  major histocompatibility complex, class ii, do alpha, TGFBR3  -  transforming growth factor, beta 
receptor iii, IRF3  -  interferon regulatory factor 3, S1PR1  -  sphingosine-1-phosphate receptor 1, BCL2  -  b-cell cll/lymphoma 2, GZMH  -  granzyme h (cathepsin g-like 2, protein h-ccpx), IL24  -  interleukin 24, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, MS4A1  -  membrane-spanning 4-domains, subfamily a, member 1, FCER1A  -  fc fragment of ige, high 
affinity i, receptor for; alpha polypeptide, GZMA  -  granzyme a (granzyme 1, cytotoxic t-lymphocyte-associated serine esterase 3), LEF1  -  lymphoid enhancer-binding factor 1, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor]
[RORA  -  rar-related orphan receptor a, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LCK  -  lymphocyte-specific protein tyrosine kinase, SLAMF7  -  slam family member 7, BLNK  -  b-cell linker, CD40  -  cd40 molecule, tnf receptor superfamily member 5, CD8A  -  cd8a molecule, DPP4  -  dipeptidyl-peptidase 4, IKZF3  -  ikaros family zinc finger 3 
(aiolos), BCL2  -  b-cell cll/lymphoma 2, MS4A1  -  membrane-spanning 4-domains, subfamily a, member 1, EOMES  -  eomesodermin, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD2  -  cd2 molecule, IL7R  -  interleukin 7 receptor, CD3D  -  cd3d 
molecule, delta (cd3-tcr complex)]
[RORA  -  rar-related orphan receptor a, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LCK  -  lymphocyte-specific protein tyrosine kinase, SLAMF7  -  slam family member 7, BLNK  -  b-cell linker, CD40  -  cd40 molecule, tnf receptor superfamily member 5, CD8A  -  cd8a molecule, DPP4  -  dipeptidyl-peptidase 4, IKZF3  -  ikaros family zinc finger 3 
(aiolos), BCL2  -  b-cell cll/lymphoma 2, MS4A1  -  membrane-spanning 4-domains, subfamily a, member 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, EOMES  -  eomesodermin, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD2  -  cd2 molecule, 
IL7R  -  interleukin 7 receptor, CD3D  -  cd3d molecule, delta (cd3-tcr complex)]
[IGHM  -  immunoglobulin heavy constant mu, CCR7  -  chemokine (c-c motif) receptor 7, IGJ  -  immunoglobulin j polypeptide, linker protein for immunoglobulin alpha and mu polypeptides, CIITA  -  class ii, major histocompatibility complex, transactivator, PRF1  -  perforin 1 (pore forming protein), KLRG1  -  killer cell lectin-like receptor subfamily g, member 
1, TRAT1  -  t cell receptor associated transmembrane adaptor 1, IGKV3-20  -  immunoglobulin kappa variable 3-20, CXCL9  -  chemokine (c-x-c motif) ligand 9, BLNK  -  b-cell linker, CD8A  -  cd8a molecule, ENPP3  -  ectonucleotide pyrophosphatase/phosphodiesterase 3, ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, CD3G  -  cd3g molecule, 
gamma (cd3-tcr complex), TNFSF10  -  tumor necrosis factor (ligand) superfamily, member 10, ETS1  -  v-ets avian erythroblastosis virus e26 oncogene homolog 1, LCK  -  lymphocyte-specific protein tyrosine kinase, SLAMF7  -  slam family member 7, CXCL10  -  chemokine (c-x-c motif) ligand 10, HLA-DMB  -  major histocompatibility complex, class ii, dm beta, 
HLA-DOA  -  major histocompatibility complex, class ii, do alpha, TGFBR3  -  transforming growth factor, beta receptor iii, IRF3  -  interferon regulatory factor 3, BCL2  -  b-cell cll/lymphoma 2, GZMH  -  granzyme h (cathepsin g-like 2, protein h-ccpx), IL24  -  interleukin 24, MS4A1  -  membrane-spanning 4-domains, subfamily a, member 1, FCER1A  -  fc 
fragment of ige, high affinity i, receptor for; alpha polypeptide, GZMA  -  granzyme a (granzyme 1, cytotoxic t-lymphocyte-associated serine esterase 3), ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor]
[CCR7  -  chemokine (c-c motif) receptor 7, RORA  -  rar-related orphan receptor a, TRAC  -  t cell receptor alpha constant, LCK  -  lymphocyte-specific protein tyrosine kinase, HLA-DMB  -  major histocompatibility complex, class ii, dm beta, CD40  -  cd40 molecule, tnf receptor superfamily member 5, HLA-DOA  -  major histocompatibility complex, class ii, do 
alpha, DPP4  -  dipeptidyl-peptidase 4, IKZF3  -  ikaros family zinc finger 3 (aiolos), BCL2  -  b-cell cll/lymphoma 2, ATM  -  ataxia telangiectasia mutated, FCER1A  -  fc fragment of ige, high affinity i, receptor for; alpha polypeptide, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD2  -  cd2 molecule, 
CD3D  -  cd3d molecule, delta (cd3-tcr complex), IL7R  -  interleukin 7 receptor, CD5  -  cd5 molecule]
[CCR7  -  chemokine (c-c motif) receptor 7, RORA  -  rar-related orphan receptor a, TRAC  -  t cell receptor alpha constant, LCK  -  lymphocyte-specific protein tyrosine kinase, HLA-DMB  -  major histocompatibility complex, class ii, dm beta, CD40  -  cd40 molecule, tnf receptor superfamily member 5, HLA-DOA  -  major histocompatibility complex, class ii, do 
alpha, DPP4  -  dipeptidyl-peptidase 4, IKZF3  -  ikaros family zinc finger 3 (aiolos), BCL2  -  b-cell cll/lymphoma 2, ATM  -  ataxia telangiectasia mutated, FCER1A  -  fc fragment of ige, high affinity i, receptor for; alpha polypeptide, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD2  -  cd2 molecule, 
CD3D  -  cd3d molecule, delta (cd3-tcr complex), IL7R  -  interleukin 7 receptor, CD5  -  cd5 molecule]
[RORA  -  rar-related orphan receptor a, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LCK  -  lymphocyte-specific protein tyrosine kinase, CD8A  -  cd8a molecule, DPP4  -  dipeptidyl-peptidase 4, BCL2  -  b-cell cll/lymphoma 2, EOMES  -  eomesodermin, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), 
CD2  -  cd2 molecule, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor, CD3D  -  cd3d molecule, delta (cd3-tcr complex)]
[RORA  -  rar-related orphan receptor a, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LCK  -  lymphocyte-specific protein tyrosine kinase, CD8A  -  cd8a molecule, DPP4  -  dipeptidyl-peptidase 4, BCL2  -  b-cell cll/lymphoma 2, EOMES  -  eomesodermin, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), 
CD2  -  cd2 molecule, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor, CD3D  -  cd3d molecule, delta (cd3-tcr complex)]
[RORA  -  rar-related orphan receptor a, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LCK  -  lymphocyte-specific protein tyrosine kinase, CD8A  -  cd8a molecule, DPP4  -  dipeptidyl-peptidase 4, BCL2  -  b-cell cll/lymphoma 2, EOMES  -  eomesodermin, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), 
CD2  -  cd2 molecule, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor, CD3D  -  cd3d molecule, delta (cd3-tcr complex)]
[CD8A  -  cd8a molecule, RORA  -  rar-related orphan receptor a, BCL2  -  b-cell cll/lymphoma 2, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LEF1  -  lymphoid enhancer-binding factor 1, EOMES  -  eomesodermin, LCK  -  lymphocyte-specific protein tyrosine kinase, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD3D  -  cd3d molecule, 
delta (cd3-tcr complex), IL7R  -  interleukin 7 receptor]
[CCR7  -  chemokine (c-c motif) receptor 7, PLEKHA1  -  pleckstrin homology domain containing, family a (phosphoinositide binding specific) member 1, KLRG1  -  killer cell lectin-like receptor subfamily g, member 1, TRAT1  -  t cell receptor associated transmembrane adaptor 1, IGKV3-20  -  immunoglobulin kappa variable 3-20, CXCL9  -  chemokine (c-x-c 
motif) ligand 9, CD8A  -  cd8a molecule, DPP4  -  dipeptidyl-peptidase 4, IKZF3  -  ikaros family zinc finger 3 (aiolos), CD160  -  cd160 molecule, ATM  -  ataxia telangiectasia mutated, INPP4B  -  inositol polyphosphate-4-phosphatase, type ii, 105kda, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), CD2  -  cd2 molecule, ETS1  -  v-ets avian erythroblastosis virus 
e26 oncogene homolog 1, CD3D  -  cd3d molecule, delta (cd3-tcr complex), CD5  -  cd5 molecule, AQP3  -  aquaporin 3 (gill blood group), RORA  -  rar-related orphan receptor a, TRAC  -  t cell receptor alpha constant, LCK  -  lymphocyte-specific protein tyrosine kinase, CXCL10  -  chemokine (c-x-c motif) ligand 10, HLA-DMB  -  major histocompatibility complex, 
class ii, dm beta, CD40  -  cd40 molecule, tnf receptor superfamily member 5, HLA-DOA  -  major histocompatibility complex, class ii, do alpha, GBP1  -  guanylate binding protein 1, interferon-inducible, IRF3  -  interferon regulatory factor 3, BCL2  -  b-cell cll/lymphoma 2, FCER1A  -  fc fragment of ige, high affinity i, receptor for; alpha polypeptide, LEF1  -  
lymphoid enhancer-binding factor 1, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor]
[RORA  -  rar-related orphan receptor a, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LCK  -  lymphocyte-specific protein tyrosine kinase, CD8A  -  cd8a molecule, DPP4  -  dipeptidyl-peptidase 4, BCL2  -  b-cell cll/lymphoma 2, EOMES  -  eomesodermin, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), 
CD2  -  cd2 molecule, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor, CD3D  -  cd3d molecule, delta (cd3-tcr complex)]
[CCR7  -  chemokine (c-c motif) receptor 7, TRAC  -  t cell receptor alpha constant, LCK  -  lymphocyte-specific protein tyrosine kinase, HLA-DMB  -  major histocompatibility complex, class ii, dm beta, CD40  -  cd40 molecule, tnf receptor superfamily member 5, HLA-DOA  -  major histocompatibility complex, class ii, do alpha, DPP4  -  dipeptidyl-peptidase 4, 
IKZF3  -  ikaros family zinc finger 3 (aiolos), BCL2  -  b-cell cll/lymphoma 2, ATM  -  ataxia telangiectasia mutated, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD2  -  cd2 molecule, CD3D  -  cd3d molecule, delta (cd3-tcr complex), IL7R  -  interleukin 7 receptor, CD5  -  cd5 molecule]
[CCR7  -  chemokine (c-c motif) receptor 7, TRAC  -  t cell receptor alpha constant, LCK  -  lymphocyte-specific protein tyrosine kinase, HLA-DMB  -  major histocompatibility complex, class ii, dm beta, CD40  -  cd40 molecule, tnf receptor superfamily member 5, DPP4  -  dipeptidyl-peptidase 4, BCL2  -  b-cell cll/lymphoma 2, FCER1A  -  fc fragment of ige, high 
affinity i, receptor for; alpha polypeptide, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD2  -  cd2 molecule, CD3D  -  cd3d molecule, delta (cd3-tcr complex), IL7R  -  interleukin 7 receptor, CD5  -  cd5 molecule]
[CCR7  -  chemokine (c-c motif) receptor 7, TRAC  -  t cell receptor alpha constant, LCK  -  lymphocyte-specific protein tyrosine kinase, HLA-DMB  -  major histocompatibility complex, class ii, dm beta, CD40  -  cd40 molecule, tnf receptor superfamily member 5, DPP4  -  dipeptidyl-peptidase 4, BCL2  -  b-cell cll/lymphoma 2, FCER1A  -  fc fragment of ige, high 
affinity i, receptor for; alpha polypeptide, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD2  -  cd2 molecule, CD3D  -  cd3d molecule, delta (cd3-tcr complex), IL7R  -  interleukin 7 receptor, CD5  -  cd5 molecule]
[RORA  -  rar-related orphan receptor a, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LCK  -  lymphocyte-specific protein tyrosine kinase, SLAMF7  -  slam family member 7, CXCL10  -  chemokine (c-x-c motif) ligand 10, CD40  -  cd40 molecule, tnf receptor superfamily member 5, BLNK  -  b-cell linker, CD8A  -  cd8a molecule, DPP4  -  dipeptidyl-
peptidase 4, IKZF3  -  ikaros family zinc finger 3 (aiolos), BCL2  -  b-cell cll/lymphoma 2, MS4A1  -  membrane-spanning 4-domains, subfamily a, member 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, EOMES  -  eomesodermin, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), CD2  -  cd2 molecule, ZAP70  -  
zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor, CD3D  -  cd3d molecule, delta (cd3-tcr complex)]
[RORA  -  rar-related orphan receptor a, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LCK  -  lymphocyte-specific protein tyrosine kinase, CD8A  -  cd8a molecule, DPP4  -  dipeptidyl-peptidase 4, BCL2  -  b-cell cll/lymphoma 2, EOMES  -  eomesodermin, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), 
CD2  -  cd2 molecule, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor, CD3D  -  cd3d molecule, delta (cd3-tcr complex)]
[P2RY10  -  purinergic receptor p2y, g-protein coupled, 10, CCR7  -  chemokine (c-c motif) receptor 7, PLEKHA1  -  pleckstrin homology domain containing, family a (phosphoinositide binding specific) member 1, EEF2K  -  eukaryotic elongation factor-2 kinase, CIITA  -  class ii, major histocompatibility complex, transactivator, IL12RB2  -  interleukin 12 receptor, 
beta 2, KLRG1  -  killer cell lectin-like receptor subfamily g, member 1, TRAT1  -  t cell receptor associated transmembrane adaptor 1, IGKV3-20  -  immunoglobulin kappa variable 3-20, CXCL9  -  chemokine (c-x-c motif) ligand 9, PTCH1  -  patched 1, AKAP12  -  a kinase (prka) anchor protein 12, BLNK  -  b-cell linker, CAMK2D  -  calcium/calmodulin-dependent 
protein kinase ii delta, CCR3  -  chemokine (c-c motif) receptor 3, CD8A  -  cd8a molecule, CD160  -  cd160 molecule, MESDC2  -  mesoderm development candidate 2, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), CD2  -  cd2 molecule, TNFSF10  -  tumor necrosis factor (ligand) superfamily, member 10, CD3D  -  cd3d molecule, delta (cd3-tcr complex), EVL  
-  enah/vasp-like, TRAC  -  t cell receptor alpha constant, IL2RB  -  interleukin 2 receptor, beta, LCK  -  lymphocyte-specific protein tyrosine kinase, CXCL10  -  chemokine (c-x-c motif) ligand 10, CD40  -  cd40 molecule, tnf receptor superfamily member 5, GBP1  -  guanylate binding protein 1, interferon-inducible, TGFBR3  -  transforming growth factor, beta 
receptor iii, IRF3  -  interferon regulatory factor 3, LPAR1  -  lysophosphatidic acid receptor 1, BCL2  -  b-cell cll/lymphoma 2, S1PR1  -  sphingosine-1-phosphate receptor 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, FCER1A  -  fc fragment of ige, high affinity i, receptor for; alpha polypeptide, LEF1  -  lymphoid enhancer-binding factor 1, KLRB1  -  killer 
cell lectin-like receptor subfamily b, member 1, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor]
[CD8A  -  cd8a molecule, RORA  -  rar-related orphan receptor a, BCL2  -  b-cell cll/lymphoma 2, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LEF1  -  lymphoid enhancer-binding factor 1, EOMES  -  eomesodermin, LCK  -  lymphocyte-specific protein tyrosine kinase, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD3D  -  cd3d molecule, 
delta (cd3-tcr complex), IL7R  -  interleukin 7 receptor, BLNK  -  b-cell linker]
[CD160  -  cd160 molecule, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, PRF1  -  perforin 1 (pore forming protein), KLRG1  -  killer cell lectin-like receptor subfamily g, member 1, CXCL9  -  chemokine (c-x-c motif) ligand 9, TRAT1  -  t cell receptor associated transmembrane adaptor 1, CCR3  -  chemokine (c-c motif) receptor 3]
[RORA  -  rar-related orphan receptor a, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LCK  -  lymphocyte-specific protein tyrosine kinase, CD8A  -  cd8a molecule, DPP4  -  dipeptidyl-peptidase 4, BCL2  -  b-cell cll/lymphoma 2, EOMES  -  eomesodermin, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), 
CD2  -  cd2 molecule, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD3D  -  cd3d molecule, delta (cd3-tcr complex), IL7R  -  interleukin 7 receptor]
[AQP3  -  aquaporin 3 (gill blood group), CCR7  -  chemokine (c-c motif) receptor 7, PLEKHA1  -  pleckstrin homology domain containing, family a (phosphoinositide binding specific) member 1, TRAC  -  t cell receptor alpha constant, LCK  -  lymphocyte-specific protein tyrosine kinase, CXCL10  -  chemokine (c-x-c motif) ligand 10, TRAT1  -  t cell receptor 
associated transmembrane adaptor 1, CXCL9  -  chemokine (c-x-c motif) ligand 9, IGKV3-20  -  immunoglobulin kappa variable 3-20, HLA-DMB  -  major histocompatibility complex, class ii, dm beta, CD40  -  cd40 molecule, tnf receptor superfamily member 5, IRF3  -  interferon regulatory factor 3, DPP4  -  dipeptidyl-peptidase 4, BCL2  -  b-cell cll/lymphoma 2, 
FCER1A  -  fc fragment of ige, high affinity i, receptor for; alpha polypeptide, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD2  -  cd2 molecule, IL7R  -  interleukin 7 receptor, CD3D  -  cd3d molecule, delta (cd3-tcr complex), ETS1  -  v-ets avian 
erythroblastosis virus e26 oncogene homolog 1, CD5  -  cd5 molecule]
[DPP4  -  dipeptidyl-peptidase 4, CCR7  -  chemokine (c-c motif) receptor 7, BCL2  -  b-cell cll/lymphoma 2, TRAC  -  t cell receptor alpha constant, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), LCK  -  lymphocyte-specific protein tyrosine kinase, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor, CD3D  -  cd3d 
molecule, delta (cd3-tcr complex), CD5  -  cd5 molecule, HLA-DMB  -  major histocompatibility complex, class ii, dm beta, CD40  -  cd40 molecule, tnf receptor superfamily member 5]
[CD8A  -  cd8a molecule, CCR7  -  chemokine (c-c motif) receptor 7, RORA  -  rar-related orphan receptor a, BCL2  -  b-cell cll/lymphoma 2, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LEF1  -  lymphoid enhancer-binding factor 1, EOMES  -  eomesodermin, LCK  -  lymphocyte-specific protein tyrosine kinase, ZAP70  -  zeta-chain (tcr) associated 
protein kinase 70kda, IL7R  -  interleukin 7 receptor, CD3D  -  cd3d molecule, delta (cd3-tcr complex), BLNK  -  b-cell linker]
[IGHM  -  immunoglobulin heavy constant mu, CCR7  -  chemokine (c-c motif) receptor 7, IGJ  -  immunoglobulin j polypeptide, linker protein for immunoglobulin alpha and mu polypeptides, PRF1  -  perforin 1 (pore forming protein), KLRG1  -  killer cell lectin-like receptor subfamily g, member 1, CXCL9  -  chemokine (c-x-c motif) ligand 9, IGKV3-20  -  
immunoglobulin kappa variable 3-20, TRAT1  -  t cell receptor associated transmembrane adaptor 1, BLNK  -  b-cell linker, CCR3  -  chemokine (c-c motif) receptor 3, CD8A  -  cd8a molecule, CD160  -  cd160 molecule, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), LCK  -  lymphocyte-specific protein tyrosine kinase, SLAMF7  -  slam family member 7, 
CXCL10  -  chemokine (c-x-c motif) ligand 10, CD40  -  cd40 molecule, tnf receptor superfamily member 5, GBP1  -  guanylate binding protein 1, interferon-inducible, APOL3  -  apolipoprotein l, 3, IRF3  -  interferon regulatory factor 3, APOL2  -  apolipoprotein l, 2, BCL2  -  b-cell cll/lymphoma 2, IL24  -  interleukin 24, CX3CR1  -  chemokine (c-x3-c motif) 
receptor 1, FCER1A  -  fc fragment of ige, high affinity i, receptor for; alpha polypeptide, PTPRCAP  -  protein tyrosine phosphatase, receptor type, c-associated protein, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda]
[CCR7  -  chemokine (c-c motif) receptor 7, TRAC  -  t cell receptor alpha constant, LCK  -  lymphocyte-specific protein tyrosine kinase, HLA-DMB  -  major histocompatibility complex, class ii, dm beta, GBP1  -  guanylate binding protein 1, interferon-inducible, HLA-DOA  -  major histocompatibility complex, class ii, do alpha, DPP4  -  dipeptidyl-peptidase 4, BCL2  
-  b-cell cll/lymphoma 2, S1PR1  -  sphingosine-1-phosphate receptor 1, SPOCK2  -  sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD2  -  cd2 molecule, IL7R  -  interleukin 7 
receptor, CD3D  -  cd3d molecule, delta (cd3-tcr complex), CD5  -  cd5 molecule]
[P2RY10  -  purinergic receptor p2y, g-protein coupled, 10, PLEKHA1  -  pleckstrin homology domain containing, family a (phosphoinositide binding specific) member 1, CIITA  -  class ii, major histocompatibility complex, transactivator, IL12RB2  -  interleukin 12 receptor, beta 2, TRAT1  -  t cell receptor associated transmembrane adaptor 1, IGKV3-20  -  
immunoglobulin kappa variable 3-20, CXCL9  -  chemokine (c-x-c motif) ligand 9, AKAP12  -  a kinase (prka) anchor protein 12, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, BLNK  -  b-cell linker, CD160  -  cd160 molecule, ATM  -  ataxia telangiectasia mutated, ING4  -  inhibitor of growth family, member 4, INPP4B  -  inositol polyphosphate-
4-phosphatase, type ii, 105kda, NR3C2  -  nuclear receptor subfamily 3, group c, member 2, EVL  -  enah/vasp-like, IL2RB  -  interleukin 2 receptor, beta, CD40  -  cd40 molecule, tnf receptor superfamily member 5, HLA-DOA  -  major histocompatibility complex, class ii, do alpha, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, KLRB1  -  killer cell lectin-like 
receptor subfamily b, member 1, IL7R  -  interleukin 7 receptor, CCR7  -  chemokine (c-c motif) receptor 7, EEF2K  -  eukaryotic elongation factor-2 kinase, PASK  -  pas domain containing serine/threonine kinase, KLRG1  -  killer cell lectin-like receptor subfamily g, member 1, PTCH1  -  patched 1, CCR3  -  chemokine (c-c motif) receptor 3, CD8A  -  cd8a 
molecule, CA8  -  carbonic anhydrase viii, MESDC2  -  mesoderm development candidate 2, PLEKHB1  -  pleckstrin homology domain containing, family b (evectins) member 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), CD2  -  cd2 molecule, TNFSF10  -  tumor necrosis factor (ligand) superfamily, member 10, CD3D  -  cd3d molecule, delta (cd3-tcr 
complex), CD5  -  cd5 molecule, RAP2A  -  rap2a, member of ras oncogene family, RORA  -  rar-related orphan receptor a, TRAC  -  t cell receptor alpha constant, LCK  -  lymphocyte-specific protein tyrosine kinase, CXCL10  -  chemokine (c-x-c motif) ligand 10, GBP1  -  guanylate binding protein 1, interferon-inducible, TGFBR3  -  transforming growth factor, 
beta receptor iii, APOL3  -  apolipoprotein l, 3, IRF3  -  interferon regulatory factor 3, LPAR1  -  lysophosphatidic acid receptor 1, AKAP5  -  a kinase (prka) anchor protein 5, S1PR1  -  sphingosine-1-phosphate receptor 1, BCL2  -  b-cell cll/lymphoma 2, SPOCK2  -  sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2, FCER1A  -  fc fragment of 
ige, high affinity i, receptor for; alpha polypeptide, LEF1  -  lymphoid enhancer-binding factor 1, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda]
[CCR7  -  chemokine (c-c motif) receptor 7, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), CIITA  -  class ii, major histocompatibility complex, transactivator, PASK  -  pas domain containing serine/threonine kinase, IL12RB2  -  interleukin 12 receptor, beta 2, PTCH1  -  patched 1, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, CCR3  -  
chemokine (c-c motif) receptor 3, IKZF3  -  ikaros family zinc finger 3 (aiolos), INPP4B  -  inositol polyphosphate-4-phosphatase, type ii, 105kda, EOMES  -  eomesodermin, CD2  -  cd2 molecule, ETS1  -  v-ets avian erythroblastosis virus e26 oncogene homolog 1, RAP2A  -  rap2a, member of ras oncogene family, AQP3  -  aquaporin 3 (gill blood group), RORA  -  
rar-related orphan receptor a, EVL  -  enah/vasp-like, LCK  -  lymphocyte-specific protein tyrosine kinase, CXCL10  -  chemokine (c-x-c motif) ligand 10, CACNA2D2  -  calcium channel, voltage-dependent, alpha 2/delta subunit 2, CD40  -  cd40 molecule, tnf receptor superfamily member 5, HLA-DOA  -  major histocompatibility complex, class ii, do alpha, GBP1  -  
guanylate binding protein 1, interferon-inducible, TGFBR3  -  transforming growth factor, beta receptor iii, IRF3  -  interferon regulatory factor 3, LPAR1  -  lysophosphatidic acid receptor 1, S1PR1  -  sphingosine-1-phosphate receptor 1, BCL2  -  b-cell cll/lymphoma 2, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, FCER1A  -  fc fragment of ige, high affinity i, 
receptor for; alpha polypeptide, LEF1  -  lymphoid enhancer-binding factor 1, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog]
[BCL2  -  b-cell cll/lymphoma 2, MS4A1  -  membrane-spanning 4-domains, subfamily a, member 1, LEF1  -  lymphoid enhancer-binding factor 1, IL7R  -  interleukin 7 receptor, CD40  -  cd40 molecule, tnf receptor superfamily member 5]
[RORA  -  rar-related orphan receptor a, PRF1  -  perforin 1 (pore forming protein), SLAMF7  -  slam family member 7, IGKV3-20  -  immunoglobulin kappa variable 3-20, CXCL9  -  chemokine (c-x-c motif) ligand 9, CXCL10  -  chemokine (c-x-c motif) ligand 10, CD40  -  cd40 molecule, tnf receptor superfamily member 5, GBP1  -  guanylate binding protein 1, 
interferon-inducible, CD8A  -  cd8a molecule, IRF3  -  interferon regulatory factor 3, BCL2  -  b-cell cll/lymphoma 2, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, EOMES  -  eomesodermin, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex)]
[CCR7  -  chemokine (c-c motif) receptor 7, S1PR1  -  sphingosine-1-phosphate receptor 1, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CXCL9  -  chemokine (c-x-c motif) ligand 9, CXCL10  -  chemokine (c-x-c motif) ligand 10]
[CCR7  -  chemokine (c-c motif) receptor 7, LCK  -  lymphocyte-specific protein tyrosine kinase, CXCL10  -  chemokine (c-x-c motif) ligand 10, CXCL9  -  chemokine (c-x-c motif) ligand 9, TRAT1  -  t cell receptor associated transmembrane adaptor 1, AKAP12  -  a kinase (prka) anchor protein 12, CD40  -  cd40 molecule, tnf receptor superfamily member 5, 
CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, CD8A  -  cd8a molecule, IRF3  -  interferon regulatory factor 3, APOL3  -  apolipoprotein l, 3, AKAP5  -  a kinase (prka) anchor protein 5, LPAR1  -  lysophosphatidic acid receptor 1, IL24  -  interleukin 24, BCL2  -  b-cell cll/lymphoma 2, FCER1A  -  fc fragment of ige, high affinity i, receptor for; 
alpha polypeptide, ATM  -  ataxia telangiectasia mutated, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, TNFSF10  -  tumor necrosis factor (ligand) superfamily, member 10]
[IGHM  -  immunoglobulin heavy constant mu, CD8A  -  cd8a molecule, IRF3  -  interferon regulatory factor 3, IGJ  -  immunoglobulin j polypeptide, linker protein for immunoglobulin alpha and mu polypeptides, CD160  -  cd160 molecule, BCL2  -  b-cell cll/lymphoma 2, PRF1  -  perforin 1 (pore forming protein), CXCL10  -  chemokine (c-x-c motif) ligand 10, 
CXCL9  -  chemokine (c-x-c motif) ligand 9, IGKV3-20  -  immunoglobulin kappa variable 3-20, CD40  -  cd40 molecule, tnf receptor superfamily member 5, GBP1  -  guanylate binding protein 1, interferon-inducible]
[DPP4  -  dipeptidyl-peptidase 4, TRAC  -  t cell receptor alpha constant, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), LCK  -  lymphocyte-specific protein tyrosine kinase, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD3D  -  cd3d molecule, delta (cd3-tcr complex), IL7R  -  interleukin 7 receptor, 
CD5  -  cd5 molecule, HLA-DMB  -  major histocompatibility complex, class ii, dm beta]
[IKZF3  -  ikaros family zinc finger 3 (aiolos), BCL2  -  b-cell cll/lymphoma 2, MS4A1  -  membrane-spanning 4-domains, subfamily a, member 1, LEF1  -  lymphoid enhancer-binding factor 1, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor, CD40  -  cd40 molecule, tnf receptor superfamily member 5, BLNK  -  b-cell linker]
[AQP3  -  aquaporin 3 (gill blood group), RORA  -  rar-related orphan receptor a, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LCK  -  lymphocyte-specific protein tyrosine kinase, CXCL9  -  chemokine (c-x-c motif) ligand 9, CXCL10  -  chemokine (c-x-c motif) ligand 10, PTCH1  -  patched 1, GBP1  -  guanylate binding protein 1, interferon-inducible, HLA-
DOA  -  major histocompatibility complex, class ii, do alpha, TGFBR3  -  transforming growth factor, beta receptor iii, IKZF3  -  ikaros family zinc finger 3 (aiolos), LPAR1  -  lysophosphatidic acid receptor 1, PLEKHB1  -  pleckstrin homology domain containing, family b (evectins) member 1, BCL2  -  b-cell cll/lymphoma 2, SPOCK2  -  sparc/osteonectin, cwcv and 
kazal-like domains proteoglycan (testican) 2, LEF1  -  lymphoid enhancer-binding factor 1, EOMES  -  eomesodermin, INPP4B  -  inositol polyphosphate-4-phosphatase, type ii, 105kda, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD2  -  cd2 molecule, ETS1  -  v-ets avian erythroblastosis virus e26 oncogene homolog 1, IL7R  -  interleukin 7 
receptor, RAP2A  -  rap2a, member of ras oncogene family, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog]
[DPP4  -  dipeptidyl-peptidase 4, CCR7  -  chemokine (c-c motif) receptor 7, TRAC  -  t cell receptor alpha constant, SPOCK2  -  sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), LCK  -  lymphocyte-specific protein tyrosine kinase, ZAP70  -  
zeta-chain (tcr) associated protein kinase 70kda, IL7R  -  interleukin 7 receptor, CD3D  -  cd3d molecule, delta (cd3-tcr complex), CD5  -  cd5 molecule, HLA-DMB  -  major histocompatibility complex, class ii, dm beta]
[RORA  -  rar-related orphan receptor a, BCL11B  -  b-cell cll/lymphoma 11b (zinc finger protein), LCK  -  lymphocyte-specific protein tyrosine kinase, CD8A  -  cd8a molecule, DPP4  -  dipeptidyl-peptidase 4, BCL2  -  b-cell cll/lymphoma 2, EOMES  -  eomesodermin, LEF1  -  lymphoid enhancer-binding factor 1, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), 
CD2  -  cd2 molecule, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD3D  -  cd3d molecule, delta (cd3-tcr complex), IL7R  -  interleukin 7 receptor]
[DPP4  -  dipeptidyl-peptidase 4, TRAC  -  t cell receptor alpha constant, CD3G  -  cd3g molecule, gamma (cd3-tcr complex), LCK  -  lymphocyte-specific protein tyrosine kinase, ZAP70  -  zeta-chain (tcr) associated protein kinase 70kda, CD2  -  cd2 molecule, IL7R  -  interleukin 7 receptor, CD3D  -  cd3d molecule, delta (cd3-tcr complex), CD5  -  cd5 molecule, HLA-
DMB  -  major histocompatibility complex, class ii, dm beta, HLA-DOA  -  major histocompatibility complex, class ii, do alpha]
